<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:dmaa="http://dmaacorp.com/20260630"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dmaa-20260630.xsd" xlink:type="simple"/>
    <context id="cref_836361269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1538570443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-27</instant>
        </period>
    </context>
    <context id="cref_886717979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_758851163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1314155591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_67661748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_981018279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_117607600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmaa:PrivateUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="cref_519137305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">dmaa:PrivateUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_1979039315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="cref_1883792367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:UnsecuredSubscriptionPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="cref_868159221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_36948847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_27942075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RepresentativeSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_10952121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RepresentativeSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1959642219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_291828659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1653239288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-11</startDate>
            <endDate>2025-03-11</endDate>
        </period>
    </context>
    <context id="cref_318403519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_892249524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1627013684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_1551556043">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_158101399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-27</startDate>
            <endDate>2025-01-27</endDate>
        </period>
    </context>
    <context id="cref_1220412094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2025-01-27</startDate>
            <endDate>2025-01-27</endDate>
        </period>
    </context>
    <context id="cref_32152629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">dmaa:ExtensionAdvanceNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_414021520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">dmaa:ExtensionAdvanceNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_259218133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">dmaa:ExtensionAdvanceNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1835452059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2026-03-23</instant>
        </period>
    </context>
    <context id="cref_374279680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-23</instant>
        </period>
    </context>
    <context id="cref_900816929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_376705632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:InterimLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1637280617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:InterimLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="cref_1895244941">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:InterimLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-23</instant>
        </period>
    </context>
    <context id="cref_458884607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1501621130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1946577256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_618941919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:SubscriptionPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_303774590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dmaa:SubscriptionPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_941713624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1834951827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_833621421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_475012269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1728766642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:CEOCompensationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1715350485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:CEOCompensationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-22</startDate>
            <endDate>2026-04-22</endDate>
        </period>
    </context>
    <context id="cref_409484284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:CEOCompensationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-22</instant>
        </period>
    </context>
    <context id="cref_962785319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:CEOCompensationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-22</instant>
        </period>
    </context>
    <context id="cref_1268456083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dmaa:MrElmasriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-22</startDate>
            <endDate>2026-04-22</endDate>
        </period>
    </context>
    <context id="cref_1885399186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dmaa:MrElmasriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-22</startDate>
            <endDate>2026-04-22</endDate>
        </period>
    </context>
    <context id="cref_1964842653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2098007255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dmaa:MrElmasriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1480518319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">dmaa:MrElmasriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1771782839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-17</startDate>
            <endDate>2025-11-17</endDate>
        </period>
    </context>
    <context id="cref_1556057871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-17</startDate>
            <endDate>2025-11-17</endDate>
        </period>
    </context>
    <context id="cref_1094306799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="cref_610905939">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_809448938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="cref_602107683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-05</instant>
        </period>
    </context>
    <context id="cref_430900391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-21</instant>
        </period>
    </context>
    <context id="cref_1181014289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-13</instant>
        </period>
    </context>
    <context id="cref_1649255541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2135065127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_863509991">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1023210724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_331261794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1369455042">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <context id="cref_831581933">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1087821693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_756791820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1622086725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_456329547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_2113912987">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="cref_438570110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="cref_995603075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="cref_1175859534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:FounderShares1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="cref_182010128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_947781037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_1105729135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1340404045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1743778701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_511249785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-18</startDate>
            <endDate>2026-02-18</endDate>
        </period>
    </context>
    <context id="cref_1828322795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-18</instant>
        </period>
    </context>
    <context id="cref_1730177644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_1919088554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_317406060">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_1811338515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dmaa:PublicRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_251817079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_2139769331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="cref_392068726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1230726302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1171296127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2075376762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1580363731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1316638507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1073265391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_140643076">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_514427604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1110935070">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_17109212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1038820876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_956868910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_712284467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_948196432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-27</instant>
        </period>
    </context>
    <context id="cref_1936457725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2026-04-27</instant>
        </period>
    </context>
    <context id="cref_993523170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-04-27</endDate>
        </period>
    </context>
    <context id="cref_475306561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_896991656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1785139069">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_251052409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_308881782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:PublicSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_427424176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_1485539063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">dmaa:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1769496835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_186836037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_1062945692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dmaa:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_1155951493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-18</startDate>
            <endDate>2025-02-18</endDate>
        </period>
    </context>
    <context id="cref_1029827157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="cref_1115277341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:PublicSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="cref_1966717652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:PublicSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="cref_1230356824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_728874592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1438914935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_639576747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_520904178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_313055635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_905558695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1341023537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_708217199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1482761260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1914140412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1153774218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1767326497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_583078146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_993831266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_807424700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1469061884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1802634865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1218977152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1405656348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1409687054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1336707000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1040376686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_667463080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1510992032">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_858326392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_871917348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_53224651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_273604104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2081848719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1368990550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_109701989">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_709005857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1587336443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
        </entity>
        <period>
            <instant>2026-08-14</instant>
        </period>
    </context>
    <context id="cref_8233153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:RightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1090571993">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1605191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dmaa:UnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1733644801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_441320974">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_47934038">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_686981971">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_296149019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2017341371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_754393542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1101421250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1310688294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1534464918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_378623981">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_254486411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1685897641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_191205926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_767284125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1122482443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1585642834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002028614</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <unit id="uref_1538570443">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_1883446565">
        <measure>shares</measure>
    </unit>
    <unit id="uref_117607600">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_379285833">
        <measure>pure</measure>
    </unit>
    <unit id="uref_1025653295">
        <measure>dmaa:Segment</measure>
    </unit>
    <us-gaap:PreferredStockValue
      contextRef="cref_981018279"
      id="fc_992323539"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_67661748"
      id="fc_937254914"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_981018279"
      id="fc_1753231344"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_67661748"
      id="fc_606121017"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_67661748"
      id="fc_327129507"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_981018279"
      id="fc_1475018095"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_67661748"
      id="fc_442072234"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_67661748"
      id="fc_1438829203"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_67661748"
      id="fc_1468483223"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_981018279"
      id="fc_1042058193"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_981018279"
      id="fc_281807047"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1733644801"
      id="fc_1733644801"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_441320974"
      id="fc_441320974"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_47934038"
      id="fc_47934038"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_686981971"
      id="fc_686981971"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_296149019"
      id="fc_296149019"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2017341371"
      id="fc_2017341371"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_993831266"
      id="fc_623159961"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares
      contextRef="cref_1469061884"
      id="fc_98514875"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares
      contextRef="cref_807424700"
      id="fc_1312971783"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares
      contextRef="cref_993831266"
      id="fc_259989345"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_1802634865"
      id="fc_226925847"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_1469061884"
      id="fc_1334281168"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_993831266"
      id="fc_1032461338"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1802634865"
      id="fc_565171182"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1469061884"
      id="fc_1499541468"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_993831266"
      id="fc_124955778"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_1802634865"
      id="fc_1151777376"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_807424700"
      id="fc_434856742"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_993831266"
      id="fc_2134718998"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_754393542"
      id="fc_754393542"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1101421250"
      id="fc_1101421250"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1802634865"
      id="fc_2090248269"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1469061884"
      id="fc_283227129"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1802634865"
      id="fc_2103800671"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1469061884"
      id="fc_1711254348"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_807424700"
      id="fc_938296940"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_754393542"
      id="fc_1481956078"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1101421250"
      id="fc_1751862096"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1368990550"
      id="fc_1865381486"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_754393542"
      id="fc_770470780"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_1101421250"
      id="fc_1790659897"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_2081848719"
      id="fc_1803754674"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_273604104"
      id="fc_269714131"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="cref_886717979"
      id="fc_1836587332"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:CapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_1230356824"
      id="fc_1410206427"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="cref_1230356824"
      id="fc_226959701"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
      contextRef="cref_886717979"
      id="fc_1729582888"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_886717979"
      id="fc_1067002905"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable
      contextRef="cref_886717979"
      id="fc_1797464467"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_886717979"
      id="fc_868547124"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:PaymentOfOfferingCosts
      contextRef="cref_886717979"
      id="fc_1902723646"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:DeferredUnderwritingFeePayable
      contextRef="cref_886717979"
      id="fc_1256571418"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ShareSubscriptionReceivable
      contextRef="cref_886717979"
      id="fc_1764841627"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:CostsIncludedInEquity
      contextRef="cref_886717979"
      id="fc_156572637"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_886717979"
      id="fc_85680587"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NotesIssued1
      contextRef="cref_886717979"
      id="fc_1273651074"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExtensionAdvanceNote
      contextRef="cref_67661748"
      id="fc_520922750"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ShareRedemptionsPayable
      contextRef="cref_67661748"
      id="fc_179086639"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1310688294"
      id="fc_1310688294"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1534464918"
      id="fc_1534464918"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1510992032"
      id="fc_1268632159"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1310688294"
      id="fc_262151503"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1534464918"
      id="fc_2143286630"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1510992032"
      id="fc_1465232417"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_378623981"
      id="fc_378623981"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_254486411"
      id="fc_254486411"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_1685897641"
      id="fc_1685897641"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_191205926"
      id="fc_191205926"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_708217199"
      id="fc_1916601801"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1685897641"
      id="fc_925393975"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1482761260"
      id="fc_1172173430"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_191205926"
      id="fc_780262773"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1685897641"
      id="fc_1908692513"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1482761260"
      id="fc_539589361"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_191205926"
      id="fc_1739982534"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_767284125"
      id="fc_767284125"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ProceedsFromRedemptionsOfCashInTrustAccount
      contextRef="cref_1230356824"
      id="fc_1682808460"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="cref_1230356824"
      id="fc_1948327279"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ExtensionDeposits
      contextRef="cref_1230356824"
      id="fc_1663563424"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:OfferingCostsPaidViaPrepaidExpense
      contextRef="cref_886717979"
      id="fc_1844689030"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_981018279"
      id="fc_1837799109"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_67661748"
      id="fc_1014489146"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_981018279"
      id="fc_2028372660"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_67661748"
      id="fc_2001317553"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="cref_1122482443"
      id="fc_1122482443"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="cref_1585642834"
      id="fc_1585642834"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:WorkingCapitalLoans
      contextRef="cref_981018279"
      id="fc_1620669820"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:WorkingCapitalLoans
      contextRef="cref_67661748"
      id="fc_1300766890"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:CashReturnedToTrustAccountForShareRedemptionsPayable
      contextRef="cref_1230356824"
      id="fc_2117960161"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_981018279"
      id="fc_730429292"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_981018279"
      id="fc_26525541"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_67661748"
      id="fc_531165682"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_67661748"
      id="fc_1421247184"
      unitRef="uref_1883446565"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_886717979" id="fc_1833366445">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_886717979"
      decimals="0"
      id="fc_1025653295"
      unitRef="uref_1025653295">1</us-gaap:NumberOfOperatingSegments>
    <dei:AmendmentFlag contextRef="cref_886717979" id="ixv-4738">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="cref_886717979" id="ixv-4739">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="cref_886717979" id="ixv-4740">0002028614</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_886717979" id="ixv-4741">Q2</dei:DocumentFiscalPeriodFocus>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares
      contextRef="cref_1310688294"
      id="fc_969392038"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares
      contextRef="cref_1534464918"
      id="fc_1201987494"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares
      contextRef="cref_667463080"
      id="fc_791060277"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShare
      contextRef="cref_1230356824"
      id="fc_450901585"
      unitRef="uref_1538570443"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="cref_886717979" id="ixv-6077">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_886717979" id="ixv-6078">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_886717979" id="ixv-6079">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_886717979" id="ixv-6080">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_886717979" id="ixv-6081">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_886717979" id="ixv-6082">001-42467</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_886717979" id="ixv-6083">DRUGS MADE IN AMERICA ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_886717979" id="ixv-6084">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_886717979" id="ixv-6085">99-2394788</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_886717979" id="ixv-6086">420 Lexington Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_886717979" id="ixv-6087">Suite 1402</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_886717979" id="ixv-6088">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_886717979" id="ixv-6089">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_886717979" id="ixv-6090">10170</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_886717979" id="ixv-6091">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_886717979" id="ixv-6092">726-7074</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_1605191127" id="ixv-6093">Units</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1605191127" id="ixv-6094">DMAAU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1605191127" id="ixv-6095">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_1090571993" id="ixv-6096">Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1090571993" id="ixv-6097">DMAA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1090571993" id="ixv-6098">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_8233153" id="ixv-6099">Rights</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_8233153" id="ixv-6100">DMAAR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_8233153" id="ixv-6101">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_886717979" id="ixv-6102">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_886717979" id="ixv-6103">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_886717979" id="ixv-6104">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_886717979" id="ixv-6105">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_886717979" id="ixv-6106">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_886717979" id="ixv-6107">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_886717979" id="ixv-6108">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1587336443"
      decimals="0"
      id="ixv-6109"
      unitRef="uref_1883446565">24276913</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6110"
      unitRef="uref_1538570443">20280</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6111"
      unitRef="uref_1538570443">6137</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6112"
      unitRef="uref_1538570443">48904</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6113"
      unitRef="uref_1538570443">6054</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6114"
      unitRef="uref_1538570443">69184</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6115"
      unitRef="uref_1538570443">12191</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6116"
      unitRef="uref_1538570443">146834251</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6117"
      unitRef="uref_1538570443">239906656</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6118"
      unitRef="uref_1538570443">146834251</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6119"
      unitRef="uref_1538570443">239906656</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6120"
      unitRef="uref_1538570443">146903435</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6121"
      unitRef="uref_1538570443">239918847</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6122"
      unitRef="uref_1538570443">254412</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6123"
      unitRef="uref_1538570443">222184</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <dmaa:AccruedOfferingCosts
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6124"
      unitRef="uref_1538570443">78988</dmaa:AccruedOfferingCosts>
    <dmaa:AccruedOfferingCosts
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6125"
      unitRef="uref_1538570443">153988</dmaa:AccruedOfferingCosts>
    <dmaa:ExtensionAdvanceNote
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6126"
      unitRef="uref_1538570443">-600000</dmaa:ExtensionAdvanceNote>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6127"
      unitRef="uref_1538570443">350000</us-gaap:NotesPayableCurrent>
    <dmaa:ShareRedemptionsPayable
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6128"
      unitRef="uref_1538570443">1661224</dmaa:ShareRedemptionsPayable>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6129"
      unitRef="uref_1538570443">2944624</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6130"
      unitRef="uref_1538570443">376172</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6131"
      unitRef="uref_1538570443">6192000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6132"
      unitRef="uref_1538570443">6900000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6133"
      unitRef="uref_1538570443">6192000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6134"
      unitRef="uref_1538570443">6900000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6135"
      unitRef="uref_1538570443">9136624</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6136"
      unitRef="uref_1538570443">7276172</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6137"
      unitRef="uref_1883446565">13559770</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6138"
      unitRef="uref_1883446565">23000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_981018279"
      decimals="2"
      id="ixv-6139"
      unitRef="uref_117607600">10.71</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_67661748"
      decimals="2"
      id="ixv-6140"
      unitRef="uref_117607600">10.43</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6141"
      unitRef="uref_1538570443">145173027</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6142"
      unitRef="uref_1538570443">239906656</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_67661748"
      decimals="4"
      id="ixv-6143"
      unitRef="uref_117607600">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_981018279"
      decimals="4"
      id="ixv-6144"
      unitRef="uref_117607600">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6145"
      unitRef="uref_1883446565">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6146"
      unitRef="uref_1883446565">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_981018279"
      decimals="4"
      id="ixv-6147"
      unitRef="uref_117607600">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_67661748"
      decimals="4"
      id="ixv-6148"
      unitRef="uref_117607600">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6149"
      unitRef="uref_1883446565">220000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6150"
      unitRef="uref_1883446565">220000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_981018279"
      decimals="0"
      id="fc_26115652"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_67661748"
      decimals="0"
      id="fc_60159976"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_981018279"
      decimals="0"
      id="fc_2114507352"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_67661748"
      decimals="0"
      id="fc_372359134"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_981018279"
      decimals="0"
      id="fc_328050879"
      unitRef="uref_1538570443">1072</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_67661748"
      decimals="0"
      id="fc_1386784382"
      unitRef="uref_1538570443">1072</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6157"
      unitRef="uref_1538570443">-7407288</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6158"
      unitRef="uref_1538570443">-7265053</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6159"
      unitRef="uref_1538570443">-7406216</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6160"
      unitRef="uref_1538570443">-7263981</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6161"
      unitRef="uref_1538570443">146903435</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6162"
      unitRef="uref_1538570443">239918847</us-gaap:LiabilitiesAndStockholdersEquity>
    <dmaa:StockIssuedDuringPeriodNumberOfSharesSubjectToCancellationAndSurrender
      contextRef="cref_981018279"
      decimals="0"
      id="fc_843230876"
      unitRef="uref_1883446565">45092</dmaa:StockIssuedDuringPeriodNumberOfSharesSubjectToCancellationAndSurrender>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6164"
      unitRef="uref_1538570443">136934</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6165"
      unitRef="uref_1538570443">131919</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6166"
      unitRef="uref_1538570443">280235</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6167"
      unitRef="uref_1538570443">462844</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6168"
      unitRef="uref_1538570443">-136934</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6169"
      unitRef="uref_1538570443">-131919</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6170"
      unitRef="uref_1538570443">-280235</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6171"
      unitRef="uref_1538570443">-462844</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6172"
      unitRef="uref_1538570443">1863831</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6173"
      unitRef="uref_1538570443">2420498</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6174"
      unitRef="uref_1538570443">3977591</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6175"
      unitRef="uref_1538570443">4005966</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6176"
      unitRef="uref_1538570443">1863831</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6177"
      unitRef="uref_1538570443">2420498</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6178"
      unitRef="uref_1538570443">3977591</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6179"
      unitRef="uref_1538570443">4005966</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6180"
      unitRef="uref_1538570443">1726897</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6181"
      unitRef="uref_1538570443">2288579</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6182"
      unitRef="uref_1538570443">3697356</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6183"
      unitRef="uref_1538570443">3543122</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6184"
      unitRef="uref_1883446565">20095314</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6185"
      unitRef="uref_1883446565">20095314</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6186"
      unitRef="uref_1883446565">23000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6187"
      unitRef="uref_1883446565">23000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6188"
      unitRef="uref_1883446565">21539633</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6189"
      unitRef="uref_1883446565">21539633</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6190"
      unitRef="uref_1883446565">19110497</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6191"
      unitRef="uref_1883446565">19110497</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_140643076"
      decimals="2"
      id="ixv-6192"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_140643076"
      decimals="2"
      id="ixv-6193"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1316638507"
      decimals="2"
      id="ixv-6194"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1316638507"
      decimals="2"
      id="ixv-6195"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_2075376762"
      decimals="2"
      id="ixv-6196"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_2075376762"
      decimals="2"
      id="ixv-6197"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1230726302"
      decimals="2"
      id="ixv-6198"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1230726302"
      decimals="2"
      id="ixv-6199"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1073265391"
      decimals="0"
      id="fc_2022202765"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1580363731"
      decimals="0"
      id="fc_1961347033"
      unitRef="uref_1883446565">10517143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1171296127"
      decimals="0"
      id="fc_560203315"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_392068726"
      decimals="0"
      id="fc_1690641320"
      unitRef="uref_1883446565">10067451</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1073265391"
      decimals="2"
      id="ixv-6204"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1580363731"
      decimals="2"
      id="ixv-6205"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1171296127"
      decimals="2"
      id="ixv-6206"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_392068726"
      decimals="2"
      id="ixv-6207"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1073265391"
      decimals="0"
      id="fc_1751589701"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1580363731"
      decimals="0"
      id="fc_1238118164"
      unitRef="uref_1883446565">10517143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1171296127"
      decimals="0"
      id="fc_113759514"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_392068726"
      decimals="0"
      id="fc_1274856978"
      unitRef="uref_1883446565">10424325</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1073265391"
      decimals="2"
      id="ixv-6212"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1580363731"
      decimals="2"
      id="ixv-6213"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1171296127"
      decimals="2"
      id="ixv-6214"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_392068726"
      decimals="2"
      id="ixv-6215"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6217"
      unitRef="uref_1883446565">45092</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesOutstanding
      contextRef="cref_709005857"
      decimals="0"
      id="ixv-6218"
      unitRef="uref_1883446565">10717143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_709005857"
      decimals="0"
      id="ixv-6219"
      unitRef="uref_1538570443">1072</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_109701989"
      decimals="0"
      id="ixv-6220"
      unitRef="uref_1538570443">-7265053</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6221"
      unitRef="uref_1538570443">-7263981</us-gaap:StockholdersEquity>
    <dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_1368990550"
      decimals="0"
      id="ixv-6222"
      unitRef="uref_1538570443">30000</dmaa:StockIssuedDuringPeriodCapitalContributionForCancellationOfAdministrativeSupportFee>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1368990550"
      decimals="0"
      id="ixv-6223"
      unitRef="uref_1538570443">30000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_2081848719"
      decimals="0"
      id="ixv-6224"
      unitRef="uref_1538570443">2083760</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_273604104"
      decimals="0"
      id="ixv-6225"
      unitRef="uref_1538570443">2113760</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2081848719"
      decimals="0"
      id="ixv-6226"
      unitRef="uref_1538570443">1970459</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_273604104"
      decimals="0"
      id="ixv-6227"
      unitRef="uref_1538570443">1970459</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_53224651"
      decimals="0"
      id="ixv-6228"
      unitRef="uref_1883446565">10717143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_53224651"
      decimals="0"
      id="ixv-6229"
      unitRef="uref_1538570443">1072</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_871917348"
      decimals="0"
      id="ixv-6230"
      unitRef="uref_1538570443">-7378354</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_858326392"
      decimals="0"
      id="ixv-6231"
      unitRef="uref_1538570443">-7377282</us-gaap:StockholdersEquity>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares
      contextRef="cref_1510992032"
      decimals="0"
      id="fc_1510992032"
      unitRef="uref_1538570443">708000</dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares
      contextRef="cref_836361269"
      decimals="0"
      id="fc_905155818"
      unitRef="uref_1538570443">708000</dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShares>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_667463080"
      decimals="0"
      id="ixv-6234"
      unitRef="uref_1538570443">2463831</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6235"
      unitRef="uref_1538570443">2463831</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_667463080"
      decimals="0"
      id="ixv-6236"
      unitRef="uref_1538570443">1726897</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_836361269"
      decimals="0"
      id="ixv-6237"
      unitRef="uref_1538570443">1726897</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1040376686"
      decimals="0"
      id="fc_132155173"
      unitRef="uref_1883446565">10717143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1040376686"
      decimals="0"
      id="fc_1040376686"
      unitRef="uref_1538570443">1072</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1336707000"
      decimals="0"
      id="fc_1336707000"
      unitRef="uref_1538570443">-7407288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_981018279"
      decimals="0"
      id="fc_1260456169"
      unitRef="uref_1538570443">-7406216</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6243"
      unitRef="uref_1883446565">45092</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesOutstanding
      contextRef="cref_1409687054"
      decimals="0"
      id="ixv-6244"
      unitRef="uref_1883446565">9857143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1409687054"
      decimals="0"
      id="ixv-6245"
      unitRef="uref_1538570443">986</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1405656348"
      decimals="0"
      id="ixv-6246"
      unitRef="uref_1538570443">34014</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1218977152"
      decimals="0"
      id="ixv-6247"
      unitRef="uref_1538570443">-279845</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1438914935"
      decimals="0"
      id="ixv-6248"
      unitRef="uref_1538570443">-244845</us-gaap:StockholdersEquity>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6249"
      unitRef="uref_1883446565">430000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1802634865"
      decimals="0"
      id="ixv-6250"
      unitRef="uref_1883446565">430000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1802634865"
      decimals="0"
      id="ixv-6251"
      unitRef="uref_1538570443">43</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1469061884"
      decimals="0"
      id="ixv-6252"
      unitRef="uref_1538570443">-1100000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_807424700"
      decimals="0"
      id="ixv-6253"
      unitRef="uref_1538570443">4299957</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6254"
      unitRef="uref_1538570443">3200000</us-gaap:StockIssuedDuringPeriodValueOther>
    <dmaa:StockIssuedDuringPeriodSharesFairValueOfRepresentativeShares
      contextRef="cref_1802634865"
      decimals="0"
      id="ixv-6255"
      unitRef="uref_1883446565">230000</dmaa:StockIssuedDuringPeriodSharesFairValueOfRepresentativeShares>
    <dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares
      contextRef="cref_1802634865"
      decimals="0"
      id="ixv-6256"
      unitRef="uref_1538570443">23</dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares>
    <dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6257"
      unitRef="uref_1538570443">23</dmaa:StockIssuedDuringPeriodValueFairValueOfRepresentativeShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_807424700"
      decimals="0"
      id="ixv-6258"
      unitRef="uref_1538570443">3424700</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6259"
      unitRef="uref_1538570443">3424700</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_807424700"
      decimals="0"
      id="ixv-6260"
      unitRef="uref_1538570443">147830</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6261"
      unitRef="uref_1538570443">147830</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_1469061884"
      decimals="0"
      id="ixv-6262"
      unitRef="uref_1538570443">247621</dmaa:ExpensesPaidByTheSponsor>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6263"
      unitRef="uref_1538570443">247621</dmaa:ExpensesPaidByTheSponsor>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_807424700"
      decimals="0"
      id="ixv-6264"
      unitRef="uref_1538570443">7610841</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_993831266"
      decimals="0"
      id="ixv-6265"
      unitRef="uref_1538570443">7299721</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6266"
      unitRef="uref_1538570443">14910562</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_993831266"
      decimals="0"
      id="ixv-6267"
      unitRef="uref_1538570443">1254543</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_583078146"
      decimals="0"
      id="ixv-6268"
      unitRef="uref_1538570443">1254543</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1767326497"
      decimals="0"
      id="ixv-6269"
      unitRef="uref_1883446565">10517143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1767326497"
      decimals="0"
      id="ixv-6270"
      unitRef="uref_1538570443">1052</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1153774218"
      decimals="0"
      id="ixv-6271"
      unitRef="uref_1538570443">-852379</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1914140412"
      decimals="0"
      id="ixv-6272"
      unitRef="uref_1538570443">-6325023</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_728874592"
      decimals="0"
      id="ixv-6273"
      unitRef="uref_1538570443">-7176350</us-gaap:StockholdersEquity>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_1482761260"
      decimals="0"
      id="ixv-6274"
      unitRef="uref_1538570443">156554</dmaa:ExpensesPaidByTheSponsor>
    <dmaa:ExpensesPaidByTheSponsor
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6275"
      unitRef="uref_1538570443">156554</dmaa:ExpensesPaidByTheSponsor>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_708217199"
      decimals="0"
      id="ixv-6276"
      unitRef="uref_1538570443">2420498</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6277"
      unitRef="uref_1538570443">2420498</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_708217199"
      decimals="0"
      id="ixv-6278"
      unitRef="uref_1538570443">2288579</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1341023537"
      decimals="0"
      id="ixv-6279"
      unitRef="uref_1538570443">2288579</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_905558695"
      decimals="0"
      id="ixv-6280"
      unitRef="uref_1883446565">10517143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_905558695"
      decimals="0"
      id="ixv-6281"
      unitRef="uref_1538570443">1052</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_313055635"
      decimals="0"
      id="ixv-6282"
      unitRef="uref_1538570443">-695825</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_520904178"
      decimals="0"
      id="ixv-6283"
      unitRef="uref_1538570443">-6456942</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_639576747"
      decimals="0"
      id="ixv-6284"
      unitRef="uref_1538570443">-7151715</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6285"
      unitRef="uref_1538570443">3697356</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6286"
      unitRef="uref_1538570443">3543122</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6287"
      unitRef="uref_1538570443">83676</us-gaap:OperatingCostsAndExpenses>
    <dmaa:CapitalContributionForCancellationOfAdministrativeSupportFee
      contextRef="cref_886717979"
      decimals="0"
      id="fc_74092419"
      unitRef="uref_1538570443">30000</dmaa:CapitalContributionForCancellationOfAdministrativeSupportFee>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6289"
      unitRef="uref_1538570443">3977591</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6290"
      unitRef="uref_1538570443">4005966</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6291"
      unitRef="uref_1538570443">42850</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6292"
      unitRef="uref_1538570443">48904</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6293"
      unitRef="uref_1538570443">-42772</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6294"
      unitRef="uref_1538570443">70173</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6295"
      unitRef="uref_1538570443">-335857</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6296"
      unitRef="uref_1538570443">-357899</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireTrustPreferredInvestments
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6297"
      unitRef="uref_1538570443">600000</us-gaap:PaymentsToAcquireTrustPreferredInvestments>
    <us-gaap:PaymentsToAcquireTrustPreferredInvestments
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6298"
      unitRef="uref_1538570443">231150000</us-gaap:PaymentsToAcquireTrustPreferredInvestments>
    <dmaa:ProceedsFromRedemptionsOfCashInTrustAccount
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6299"
      unitRef="uref_1538570443">99311220</dmaa:ProceedsFromRedemptionsOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6300"
      unitRef="uref_1538570443">98711220</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6301"
      unitRef="uref_1538570443">-231150000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6302"
      unitRef="uref_1538570443">350000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6303"
      unitRef="uref_1538570443">99311220</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <dmaa:ExtensionDeposits
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6304"
      unitRef="uref_1538570443">600000</dmaa:ExtensionDeposits>
    <dmaa:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6305"
      unitRef="uref_1538570443">228850000</dmaa:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6306"
      unitRef="uref_1538570443">3200000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6307"
      unitRef="uref_1538570443">-354175</dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6308"
      unitRef="uref_1538570443">900000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <dmaa:PaymentOfOfferingCosts
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6309"
      unitRef="uref_1538570443">-3195</dmaa:PaymentOfOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6310"
      unitRef="uref_1538570443">-98361220</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6311"
      unitRef="uref_1538570443">231507370</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6312"
      unitRef="uref_1538570443">14143</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6313"
      unitRef="uref_1538570443">-529</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6314"
      unitRef="uref_1538570443">6137</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1438914935"
      decimals="0"
      id="ixv-6315"
      unitRef="uref_1538570443">1351</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6316"
      unitRef="uref_1538570443">20280</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_728874592"
      decimals="0"
      id="ixv-6317"
      unitRef="uref_1538570443">822</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <dmaa:CashReturnedToTrustAccountForShareRedemptionsPayable
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6318"
      unitRef="uref_1538570443">1661224</dmaa:CashReturnedToTrustAccountForShareRedemptionsPayable>
    <dmaa:ShareSubscriptionReceivable
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6319"
      unitRef="uref_1538570443">1100000</dmaa:ShareSubscriptionReceivable>
    <us-gaap:NotesIssued1
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6320"
      unitRef="uref_1538570443">204000</us-gaap:NotesIssued1>
    <dmaa:AccretionAndRemeasurementOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6321"
      unitRef="uref_1538570443">-4577591</dmaa:AccretionAndRemeasurementOfRedeemableOrdinarySharesToRedemptionValue>
    <dmaa:AccretionAndRemeasurementOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6322"
      unitRef="uref_1538570443">-17331060</dmaa:AccretionAndRemeasurementOfRedeemableOrdinarySharesToRedemptionValue>
    <dmaa:CostsIncludedInEquity
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6323"
      unitRef="uref_1538570443">848201</dmaa:CostsIncludedInEquity>
    <dmaa:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6324"
      unitRef="uref_1538570443">94516</dmaa:OfferingCostsIncludedInAccruedOfferingCosts>
    <dmaa:DeferredUnderwritingFeePayable
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6325"
      unitRef="uref_1538570443">6900000</dmaa:DeferredUnderwritingFeePayable>
    <dmaa:OfferingCostsPaidViaPrepaidExpense
      contextRef="cref_1230356824"
      decimals="0"
      id="ixv-6326"
      unitRef="uref_1538570443">3640</dmaa:OfferingCostsPaidViaPrepaidExpense>
    <dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShare
      contextRef="cref_886717979"
      decimals="0"
      id="fc_512829816"
      unitRef="uref_1538570443">708000</dmaa:ReductionToDeferredUnderwritingFeePayableFromRedemptionOfClassAOrdinaryShare>
    <us-gaap:NatureOfOperations contextRef="cref_886717979" id="ixv-2831">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE &lt;span&gt;1&lt;/span&gt; &#x2014; DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS, AND GOING CONCERN&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Drugs Made In America Acquisition Corp. (the &#x201c;Company&#x201d;) is a blank check company newly incorporated in the Cayman Islands on May&#160;23, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June 30, 2026, the Company had not commenced any operations. All activity for the period from May 23, 2024 (inception) through June 30, 2026 relates to the Company&#x2019;s formation, the initial public offering (&#x201c;Initial Public Offering&#x201d;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 7, 2025 and the post-effective amendment to the registration statement was declared effective on January 27, 2025. On January 29, 2025, the Company consummated the Initial Public Offering of 20,000,000 units (the &#x201c;Units&#x201d; and, with respect to the ordinary shares included in the Units being offered, the &#x201c;Public Shares&#x201d;) at $10.00 per Unit, generating proceeds of $200,000,000, which is described in Note &lt;span&gt;3&lt;/span&gt;. On February 18, 2025, the underwriters exercised their over-allotment option to purchase an additional 3,000,000 Units at a purchase price of $10.00 per Unit, generating additional gross proceeds of $30,000,000, which is described in Note &lt;span&gt;3&lt;/span&gt;. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 400,000 units (the &#x201c;Private Placement Units&#x201d;) at a price of $10.00 per Private Placement Unit in a private placement to Drugs Made In America Acquisition LLC (the &#x201c;Sponsor&#x201d;), for $4,000,000, of which $1,100,000 was not received and included as share subscription receivable. Since the Initial Public Offering until June 30, 2026, the Sponsor has paid $649,078 in expenses on behalf of the Company (including $108,300 related to the administrative support agreement) and has since defaulted on the share subscription receivable (see Note &lt;span&gt;8&lt;/span&gt;), resulting in a share subscription receivable of $0 on the balance sheet. Simultaneously with the sale of the over-allotment option Units on February 18, 2025, the Sponsor purchased an additional 30,000 Private Placement Units at a purchase price of $10.00 per Private Placement Unit, generating additional gross proceeds of $300,000. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting fees and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial business combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Following the closing of the Initial Public Offering on January 29, 2025 and the over-allotment option closing on February 18, 2025 an amount of $231,150,000 ($10.05 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (&#x201c;Trust Account&#x201d;), located in the United States and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and/or held as cash or cash items (including in demand deposit accounts), as determined by the Company, until the earlier of: (i) the completion of a Business Combination; (ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with its initial business combination or to redeem 100% of the Public Shares if the Company does not complete its initial business combination within the Combination Period (as defined below) or (B) with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial business combination activity; and (iii)&#160;the redemption of the Public Shares if the Company has not completed an initial business combination within the Combination Period, subject to applicable law, as described below. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Transaction costs amounted to $8,898,201 consisting of $1,150,000 of cash underwriting fees, $6,900,000 of deferred underwriting fees, and $848,201 of other offering costs. As of June 30, 2026, the deferred underwriting fee payable has been reduced to $6,192,000 (see Note 7). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection with a shareholder meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#x2019;s rights. The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company&#x2019;s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The initial shareholders and the Company&#x2019;s officers and directors have entered into a letter agreement, pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to any founder shares, private shares and public shares held by them in connection with the completion of the initial Business Combination, (ii)&#160;waive their redemption rights with respect to any founder shares, private shares and public shares held by them in connection with a shareholders&#x2019; vote to amend the amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period (as defined below) or (B) with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial business combination activity; and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares and private shares they hold if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders for a vote, the initial shareholders, directors and officers have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement, to vote any shares held by them in favor of the initial Business Combination. Pursuant to the sponsor standstill, non-voting and cooperation acknowledgement entered into on March 19, 2026 (the &#x201c;Standstill Acknowledgement&#x201d;), the sole member of the Sponsor, along with her spouse, have agreed to not vote, direct the voting of, or otherwise exercise any voting rights with respect to any shares or securities of the Company held directly or indirectly with the Sponsor. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;       &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt; The underwriters have agreed to waive their rights to their deferred underwriting commissions (see Note &lt;span&gt;7&lt;/span&gt;) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company would have until 15 months from the closing of the Initial Public Offering (April &lt;span&gt;29&lt;/span&gt;, &lt;span&gt;2026&lt;/span&gt;) to complete a Business Combination. On April 27, 2026, the Company held an extraordinary general meeting of shareholders (the &#x201c;Extension Meeting&#x201d;), which approved a proposal to amend its Second Amended and Restated Memorandum and Articles of Association (the &#x201c;Existing Charter&#x201d;) by adopting an amendment to the Existing Charter which reflects the extension of the Combination Period up to twelve &lt;span&gt;(12&lt;/span&gt;) times from April 29, 2026 (the &#x201c;Termination Date&#x201d;) to April 29, 2027, each by an additional one &lt;span&gt;(1&lt;/span&gt;) month (each an &#x201c;Extension&#x201d;) for a total of &lt;span&gt;12&lt;/span&gt; months after the Termination Date, assuming a Business Combination has not occurred, so long as the Company deposits the lessor of $300,000 or $0.04 per non redeemed public share for each one-month extension period into the Trust Account. As of June 30, 2026, the Company has exercised two &lt;span&gt;(2&lt;/span&gt;) extensions, with BV Advisory Partners, LLC (the &#x201c;Investor&#x201d;) depositing an aggregate of $600,000 into the Trust Account on behalf of the Company. If the Company is unable to consummate an initial business combination within the Combination Period then effective, the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten&#160;business&#160;days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (net of funds withdrawn to pay taxes, if any, and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and board of directors, liquidate and dissolve, subject, in each case, to the obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the shareholders&#x2019; vote at the Extension Meeting on April 27, 2026, holders of 9,440,230 ordinary shares of the Company exercised their right to redeem such shares (the &#x201c;Redemption&#x201d;) for a pro rata portion of the funds held in the Trust Account. As a result, $99,311,220 (approximately $10.52 per share) were removed from the Trust Account to pay such holders. $1,661,224 of amounts paid to one shareholder was returned to the Trust Account, resulting in a $1,661,224 share redemptions payable balance as of June 30, 2026, representing the amount that will be repaid to the shareholder in full. Following the aforementioned Redemption, the Company has 24,276,913 ordinary shares outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)&#160;$10.05 per Public Share and (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#x2019;s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 29, 2026, the Company entered into a Definitive Merger Agreement (the &#x201c;Merger Agreement&#x201d;) with PAGC. The Merger Agreement provides for a business combination pursuant to which PAGC will merge with and into the Company (or a wholly-owned subsidiary of the Company, as may be mutually agreed by the parties), with the surviving entity continuing as the Company&#x2019;s combined operating business following the closing (the &#x201c;Merger&#x201d;). Following the consummation of the Merger, the surviving entity is intended to operate as a publicly traded company on The Nasdaq Stock Market LLC.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Going Concern Consideration&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, the Company had $20,280 and $6,137 in cash, respectively, and a working capital deficit of $2,875,440 and $363,981, respectively. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. Additionally, the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. These conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through a Business Combination. There is no assurance that the Company&#x2019;s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. &lt;/p&gt;</us-gaap:NatureOfOperations>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_886717979" id="ixv-6328">2024-05-23</dei:EntityIncorporationDateOfIncorporation>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1115277341"
      decimals="0"
      id="ixv-6329"
      unitRef="uref_1883446565">20000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1966717652"
      decimals="2"
      id="ixv-6330"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1115277341"
      decimals="0"
      id="ixv-6331"
      unitRef="uref_1538570443">200000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_427424176"
      decimals="0"
      id="ixv-6332"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1029827157"
      decimals="2"
      id="ixv-6333"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <dmaa:ProceedsFromOverAllotmentOption
      contextRef="cref_427424176"
      decimals="0"
      id="ixv-6334"
      unitRef="uref_1538570443">30000000</dmaa:ProceedsFromOverAllotmentOption>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1155951493"
      decimals="0"
      id="ixv-6335"
      unitRef="uref_1883446565">400000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_186836037"
      decimals="2"
      id="ixv-6336"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1062945692"
      decimals="0"
      id="ixv-6337"
      unitRef="uref_1538570443">4000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <dmaa:AccruedSubscriptionReceivable
      contextRef="cref_186836037"
      decimals="0"
      id="ixv-6338"
      unitRef="uref_1538570443">1100000</dmaa:AccruedSubscriptionReceivable>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1769496835"
      decimals="0"
      id="ixv-6339"
      unitRef="uref_1538570443">649078</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1485539063"
      decimals="0"
      id="ixv-6340"
      unitRef="uref_1538570443">108300</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable
      contextRef="cref_896991656"
      decimals="0"
      id="ixv-6341"
      unitRef="uref_1538570443">0</us-gaap:StockholdersEquityNoteSubscriptionsReceivable>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_182010128"
      decimals="0"
      id="ixv-6342"
      unitRef="uref_1883446565">30000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_947781037"
      decimals="2"
      id="ixv-6343"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_182010128"
      decimals="0"
      id="ixv-6344"
      unitRef="uref_1538570443">300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <dmaa:ConditionForFutureBusinessCombinationUseOfProceedsPercentage
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6345"
      unitRef="uref_379285833">0.80</dmaa:ConditionForFutureBusinessCombinationUseOfProceedsPercentage>
    <dmaa:ConditionForFutureBusinessCombinationThresholdPercentageOwnership
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6346"
      unitRef="uref_379285833">0.50</dmaa:ConditionForFutureBusinessCombinationThresholdPercentageOwnership>
    <dmaa:ProceedsFromSaleOfUnits
      contextRef="cref_427424176"
      decimals="0"
      id="ixv-6347"
      unitRef="uref_1538570443">231150000</dmaa:ProceedsFromSaleOfUnits>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_308881782"
      decimals="2"
      id="ixv-6348"
      unitRef="uref_117607600">10.05</us-gaap:SaleOfStockPricePerShare>
    <dmaa:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="cref_981018279"
      decimals="2"
      id="ixv-6349"
      unitRef="uref_379285833">1</dmaa:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <dmaa:TransactionCosts
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6350"
      unitRef="uref_1538570443">8898201</dmaa:TransactionCosts>
    <dmaa:CashUnderwritingFees
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6351"
      unitRef="uref_1538570443">1150000</dmaa:CashUnderwritingFees>
    <dmaa:DeferredUnderwritingFees
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6352"
      unitRef="uref_1538570443">6900000</dmaa:DeferredUnderwritingFees>
    <dmaa:OtherOfferingCosts
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6353"
      unitRef="uref_1538570443">848201</dmaa:OtherOfferingCosts>
    <dmaa:DeferredUnderwritingFeePayable
      contextRef="cref_251052409"
      decimals="0"
      id="ixv-6354"
      unitRef="uref_1538570443">6192000</dmaa:DeferredUnderwritingFeePayable>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1785139069"
      decimals="2"
      id="ixv-6355"
      unitRef="uref_117607600">10.05</us-gaap:SaleOfStockPricePerShare>
    <dmaa:RedemptionLimitPercentageWithoutPriorConsent
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6356"
      unitRef="uref_379285833">0.15</dmaa:RedemptionLimitPercentageWithoutPriorConsent>
    <dmaa:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="cref_981018279"
      decimals="2"
      id="ixv-6357"
      unitRef="uref_379285833">1</dmaa:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_896991656"
      decimals="2"
      id="ixv-6358"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <dmaa:PeriodFromClosingOfPublicOfferingToCompleteBusinessCombination contextRef="cref_886717979" id="ixv-6359">P15M</dmaa:PeriodFromClosingOfPublicOfferingToCompleteBusinessCombination>
    <dmaa:TerminationDateOfBusinessCombinationPeriod contextRef="cref_886717979" id="ixv-6360">2026-04-29</dmaa:TerminationDateOfBusinessCombinationPeriod>
    <dmaa:ExtensionOnTerminationDateOfBusinessCombinationPeriod contextRef="cref_886717979" id="ixv-6361">2027-04-29</dmaa:ExtensionOnTerminationDateOfBusinessCombinationPeriod>
    <us-gaap:Deposits
      contextRef="cref_475306561"
      decimals="0"
      id="ixv-6362"
      unitRef="uref_1538570443">300000</us-gaap:Deposits>
    <dmaa:NonRedeemedPublicPerShare
      contextRef="cref_1743778701"
      decimals="2"
      id="ixv-6363"
      unitRef="uref_117607600">0.04</dmaa:NonRedeemedPublicPerShare>
    <dmaa:ExtensionDeposit
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6364"
      unitRef="uref_1538570443">600000</dmaa:ExtensionDeposit>
    <dmaa:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6365"
      unitRef="uref_1538570443">100000</dmaa:MaximumNetInterestToPayDissolutionExpenses>
    <dmaa:ExercisedRedemptionShares
      contextRef="cref_993523170"
      decimals="0"
      id="ixv-6366"
      unitRef="uref_1883446565">9440230</dmaa:ExercisedRedemptionShares>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_1936457725"
      decimals="0"
      id="ixv-6367"
      unitRef="uref_1538570443">99311220</us-gaap:AssetsHeldInTrust>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1936457725"
      decimals="2"
      id="ixv-6368"
      unitRef="uref_117607600">10.52</us-gaap:SharesIssuedPricePerShare>
    <dmaa:PaymentForShareholders
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6369"
      unitRef="uref_1538570443">1661224</dmaa:PaymentForShareholders>
    <dmaa:ShareRedemptionsPayable
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6370"
      unitRef="uref_1538570443">1661224</dmaa:ShareRedemptionsPayable>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_948196432"
      decimals="0"
      id="ixv-6371"
      unitRef="uref_1883446565">24276913</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_981018279"
      decimals="2"
      id="ixv-6372"
      unitRef="uref_117607600">10.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:Cash
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6373"
      unitRef="uref_1538570443">20280</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6374"
      unitRef="uref_1538570443">6137</us-gaap:Cash>
    <dmaa:WorkingCapitalDeficit
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6375"
      unitRef="uref_1538570443">2875440</dmaa:WorkingCapitalDeficit>
    <dmaa:WorkingCapitalDeficit
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6376"
      unitRef="uref_1538570443">363981</dmaa:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_886717979" id="ixv-2903">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 2 &#x2014; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $20,280 and $6,137 in cash and no cash equivalents as of June 30, 2026, and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, cash and investments held in the Trust Account of $146,834,251 and $239,906,656, respectively, were held in money market funds which invest in U.S. Treasury securities. All the Company&#x2019;s cash and investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of cash and investments held in the Trust Account are included in interest earned on cash and investments held in Trust Account in the accompanying statement of operations. The estimated fair values of cash and investments held in Trust Account are determined using available market information. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014; &#x201c;Expenses of Offering&#x201d;. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between ordinary shares and rights, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the rights and then to the ordinary shares. Offering costs allocated to the ordinary shares were charged to temporary equity and offering costs allocated to the public and private placement rights were charged to shareholders&#x2019; deficit as public and private placement rights after management&#x2019;s evaluation were accounted for under equity treatment.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for income taxes under ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1837799109;"&gt;&lt;span style="-sec-ix-hidden:fc_1014489146;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_2028372660;"&gt;&lt;span style="-sec-ix-hidden:fc_2001317553;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC&#160;820, &#x201c;Fair&#160;Value Measurement,&#x201d; approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Redeemable Share Classification&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Rights (as defined below)) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period.&#160;Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. Accordingly, as of June 30, 2026, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s balance sheets. Increases or decreases in the carrying amount of redeemable shares are affected by charges against additional paid-in capital and accumulated deficit. As of June 30, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;200,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,978,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(7,703,027&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;3,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;30,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(446,700&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(1,047,367&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;22,081,750&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;239,906,656&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,113,760&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;242,020,416&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement for redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,863,831&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Redemption of Ordinary shares by shareholders&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(9,440,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(99,311,220&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Extension Deposits&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;600,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;13,559,770&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;145,173,027&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Derivative Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12&#160;months of the balance sheets date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and was accounted for as a liability pursuant to ASC&#160;480 since it was not exercised at the time of the Initial Public Offering.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income (Loss) Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as redeemable ordinary shares and non-redeemable ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. This presentation assumes a Business Combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The calculation of diluted net income (loss) per ordinary share does not consider the effect of the rights issued in connection with the Initial Public Offering and the private placement of the Private Placement Units to receive an aggregate of 2,928,750 ordinary shares in the calculation of diluted income (loss) per ordinary share, because their issuance is contingent upon future events. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has considered the effect of non-redeemable ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each class of ordinary shares for the three and six months ended June 30, 2026 and 2025:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,320,616&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,222,506&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,067,451&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,292,576&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,250,456&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,424,325&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, &#x201c;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d; (&#x201c;ASU 2024-03&#x201d;), and in January 2025 issued ASU 2025-01 &#x201c;Income Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date&#x201d; (&#x201c;ASU-2025-01&#x201d;). ASU 2024-03 and ASU 2025-01 require public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026, and for interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03 and ASU 2025-01.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-04, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments&#x201d;. The amendments in this ASU clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or debt extinguishments. The amendments introduce a preexisting contract approach for evaluating whether induced conversion accounting is appropriate and provide additional guidance regarding the form and amount of consideration transferred in an inducement offer. The standard is effective for fiscal years beginning after December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on its financial statements and related disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-11, &#x201c;Interim Reporting (Topic 270): Narrow-Scope Improvements&#x201d; (&#x201c;ASU 2025-11&#x201d;), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In April 2026, the FASB issued Accounting Standards Update 2026-01, &#x201c;Initial Measurement of Paid-in-Kind Dividends on Equity-Classified preferred Stock&#x201d;, which provides authoritative guidance on how an issuer should initially measure paid-in-kind (&#x201c;PIK&#x201d;) dividends on equity-classified preferred stock. ASU 2026-01 is effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal year reporting periods. Early adoption is permitted in an interim or fiscal year reporting period in which financial statements have not yet been issued or made available for issuance. The Company does not believe ASU 2026-01 will have a significant impact on the Company&#x2019;s financial position, results of operations or cash flows. However, the Company would need to evaluate its impact in the event the Company issues preference shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statement.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_886717979" id="ixv-2907">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <dmaa:EmergingGrowthCompanyPolicyTextBlock contextRef="cref_886717979" id="ixv-2916">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</dmaa:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_886717979" id="ixv-2932">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_886717979" id="ixv-2941">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $20,280 and $6,137 in cash and no cash equivalents as of June 30, 2026, and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6377"
      unitRef="uref_1538570443">20280</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6378"
      unitRef="uref_1538570443">6137</us-gaap:Cash>
    <us-gaap:InvestmentPolicyTextBlock contextRef="cref_886717979" id="ixv-2948">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, cash and investments held in the Trust Account of $146,834,251 and $239,906,656, respectively, were held in money market funds which invest in U.S. Treasury securities. All the Company&#x2019;s cash and investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of cash and investments held in the Trust Account are included in interest earned on cash and investments held in Trust Account in the accompanying statement of operations. The estimated fair values of cash and investments held in Trust Account are determined using available market information. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6379"
      unitRef="uref_1538570443">146834251</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6380"
      unitRef="uref_1538570443">239906656</us-gaap:AssetsHeldInTrustNoncurrent>
    <dmaa:OfferingCostsPolicyTextBlock contextRef="cref_886717979" id="ixv-2955">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014; &#x201c;Expenses of Offering&#x201d;. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between ordinary shares and rights, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the rights and then to the ordinary shares. Offering costs allocated to the ordinary shares were charged to temporary equity and offering costs allocated to the public and private placement rights were charged to shareholders&#x2019; deficit as public and private placement rights after management&#x2019;s evaluation were accounted for under equity treatment.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</dmaa:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_886717979" id="ixv-2962">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for income taxes under ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1837799109;"&gt;&lt;span style="-sec-ix-hidden:fc_1014489146;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_2028372660;"&gt;&lt;span style="-sec-ix-hidden:fc_2001317553;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_886717979" id="ixv-2986">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC&#160;820, &#x201c;Fair&#160;Value Measurement,&#x201d; approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_886717979" id="ixv-2993">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Redeemable Share Classification&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Rights (as defined below)) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period.&#160;Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. Accordingly, as of June 30, 2026, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s balance sheets. Increases or decreases in the carrying amount of redeemable shares are affected by charges against additional paid-in capital and accumulated deficit. As of June 30, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;200,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,978,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(7,703,027&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;3,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;30,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(446,700&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(1,047,367&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;22,081,750&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;239,906,656&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,113,760&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;242,020,416&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement for redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,863,831&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Redemption of Ordinary shares by shareholders&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(9,440,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(99,311,220&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Extension Deposits&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;600,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;13,559,770&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;145,173,027&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_886717979" id="ixv-6381">As of June 30, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;200,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,978,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(7,703,027&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Gross proceeds from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;3,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;30,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Proceeds allocated to Public Rights from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(446,700&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary share issuance cost from exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(1,047,367&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Exercise of over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;305,179&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-indent: -9pt; padding-left: 9pt;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;22,081,750&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;239,906,656&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement of redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,113,760&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;242,020,416&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Accretion and remeasurement for redeemable ordinary shares to redemption amount&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,863,831&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;Redemption of Ordinary shares by shareholders&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(9,440,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(99,311,220&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Extension Deposits&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;600,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;Ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;13,559,770&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;145,173,027&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6382"
      unitRef="uref_1883446565">20000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6383"
      unitRef="uref_1538570443">200000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <dmaa:ProceedsAllocatedToPublicRights
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6384"
      unitRef="uref_1538570443">2978000</dmaa:ProceedsAllocatedToPublicRights>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6385"
      unitRef="uref_1538570443">305179</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6386"
      unitRef="uref_1538570443">7703027</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <dmaa:StockIssuedDuringPeriodGrossProceedsFromExerciseOfOverallotmentOption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6387"
      unitRef="uref_1883446565">3000000</dmaa:StockIssuedDuringPeriodGrossProceedsFromExerciseOfOverallotmentOption>
    <dmaa:GrossProceedsFromExerciseOfOverallotmentOption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6388"
      unitRef="uref_1538570443">30000000</dmaa:GrossProceedsFromExerciseOfOverallotmentOption>
    <dmaa:ProceedsAllocatedToPublicRightsFromExerciseOfOverallotmentOption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6389"
      unitRef="uref_1538570443">446700</dmaa:ProceedsAllocatedToPublicRightsFromExerciseOfOverallotmentOption>
    <dmaa:OrdinaryShareIssuanceCostFromExerciseOfOverallotmentOption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6390"
      unitRef="uref_1538570443">1047367</dmaa:OrdinaryShareIssuanceCostFromExerciseOfOverallotmentOption>
    <dmaa:ExerciseOfOverallotmentOption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6391"
      unitRef="uref_1538570443">305179</dmaa:ExerciseOfOverallotmentOption>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6392"
      unitRef="uref_1538570443">-22081750</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption
      contextRef="cref_712284467"
      decimals="0"
      id="ixv-6393"
      unitRef="uref_1883446565">23000000</dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_956868910"
      decimals="0"
      id="ixv-6394"
      unitRef="uref_1538570443">239906656</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_1038820876"
      decimals="0"
      id="ixv-6395"
      unitRef="uref_1538570443">-2113760</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption
      contextRef="cref_1038820876"
      decimals="0"
      id="ixv-6396"
      unitRef="uref_1883446565">23000000</dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_17109212"
      decimals="0"
      id="ixv-6397"
      unitRef="uref_1538570443">242020416</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_1110935070"
      decimals="0"
      id="ixv-6398"
      unitRef="uref_1538570443">-1863831</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <dmaa:ExercisedRedemptionShares
      contextRef="cref_1110935070"
      decimals="0"
      id="ixv-6399"
      unitRef="uref_1883446565">-9440230</dmaa:ExercisedRedemptionShares>
    <dmaa:ExercisedRedemptionSharesAmount
      contextRef="cref_1110935070"
      decimals="0"
      id="ixv-6400"
      unitRef="uref_1538570443">-99311220</dmaa:ExercisedRedemptionSharesAmount>
    <dmaa:ExtensionDeposits
      contextRef="cref_1110935070"
      decimals="0"
      id="ixv-6401"
      unitRef="uref_1538570443">600000</dmaa:ExtensionDeposits>
    <dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption
      contextRef="cref_1110935070"
      decimals="0"
      id="ixv-6402"
      unitRef="uref_1883446565">13559770</dmaa:TemporaryEquitySharesIssuedDuringPeriodOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_514427604"
      decimals="0"
      id="ixv-6403"
      unitRef="uref_1538570443">145173027</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:DerivativesPolicyTextBlock contextRef="cref_886717979" id="ixv-3229">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Derivative Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12&#160;months of the balance sheets date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and was accounted for as a liability pursuant to ASC&#160;480 since it was not exercised at the time of the Initial Public Offering.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_886717979" id="ixv-3236">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income (Loss) Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as redeemable ordinary shares and non-redeemable ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. This presentation assumes a Business Combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The calculation of diluted net income (loss) per ordinary share does not consider the effect of the rights issued in connection with the Initial Public Offering and the private placement of the Private Placement Units to receive an aggregate of 2,928,750 ordinary shares in the calculation of diluted income (loss) per ordinary share, because their issuance is contingent upon future events. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has considered the effect of non-redeemable ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each class of ordinary shares for the three and six months ended June 30, 2026 and 2025:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,320,616&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,222,506&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,067,451&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,292,576&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,250,456&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,424,325&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6404"
      unitRef="uref_1883446565">2928750</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_886717979" id="ixv-3247">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each class of ordinary shares for the three and six months ended June 30, 2026 and 2025:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,126,250&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;600,647&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;20,095,314&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,570,460&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;718,119&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;23,000,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,517,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,468,929&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,228,427&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;21,539,633&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,717,143&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-redeemable&lt;br/&gt; shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2,320,616&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,222,506&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,067,451&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Basic net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,292,576&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,250,456&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;19,110,497&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;10,424,325&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Diluted net income per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6405"
      unitRef="uref_1538570443">1126250</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1073265391"
      decimals="0"
      id="ixv-6406"
      unitRef="uref_1538570443">600647</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6407"
      unitRef="uref_1883446565">20095314</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1073265391"
      decimals="0"
      id="ixv-6408"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_140643076"
      decimals="2"
      id="ixv-6409"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1073265391"
      decimals="2"
      id="ixv-6410"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6411"
      unitRef="uref_1538570443">1126250</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1073265391"
      decimals="0"
      id="ixv-6412"
      unitRef="uref_1538570443">600647</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_140643076"
      decimals="0"
      id="ixv-6413"
      unitRef="uref_1883446565">20095314</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1073265391"
      decimals="0"
      id="ixv-6414"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_140643076"
      decimals="2"
      id="ixv-6415"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1073265391"
      decimals="2"
      id="ixv-6416"
      unitRef="uref_117607600">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6417"
      unitRef="uref_1538570443">1570460</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1580363731"
      decimals="0"
      id="ixv-6418"
      unitRef="uref_1538570443">718119</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6419"
      unitRef="uref_1883446565">23000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1580363731"
      decimals="0"
      id="ixv-6420"
      unitRef="uref_1883446565">10517143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1316638507"
      decimals="2"
      id="ixv-6421"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1580363731"
      decimals="2"
      id="ixv-6422"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6423"
      unitRef="uref_1538570443">1570460</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1580363731"
      decimals="0"
      id="ixv-6424"
      unitRef="uref_1538570443">718119</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1316638507"
      decimals="0"
      id="ixv-6425"
      unitRef="uref_1883446565">23000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1580363731"
      decimals="0"
      id="ixv-6426"
      unitRef="uref_1883446565">10517143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1316638507"
      decimals="2"
      id="ixv-6427"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1580363731"
      decimals="2"
      id="ixv-6428"
      unitRef="uref_117607600">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6429"
      unitRef="uref_1538570443">2468929</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1171296127"
      decimals="0"
      id="ixv-6430"
      unitRef="uref_1538570443">1228427</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6431"
      unitRef="uref_1883446565">21539633</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1171296127"
      decimals="0"
      id="ixv-6432"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_2075376762"
      decimals="2"
      id="ixv-6433"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1171296127"
      decimals="2"
      id="ixv-6434"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6435"
      unitRef="uref_1538570443">2468929</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1171296127"
      decimals="0"
      id="ixv-6436"
      unitRef="uref_1538570443">1228427</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_2075376762"
      decimals="0"
      id="ixv-6437"
      unitRef="uref_1883446565">21539633</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1171296127"
      decimals="0"
      id="ixv-6438"
      unitRef="uref_1883446565">10717143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_2075376762"
      decimals="2"
      id="ixv-6439"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1171296127"
      decimals="2"
      id="ixv-6440"
      unitRef="uref_117607600">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6441"
      unitRef="uref_1538570443">2320616</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_392068726"
      decimals="0"
      id="ixv-6442"
      unitRef="uref_1538570443">1222506</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6443"
      unitRef="uref_1883446565">19110497</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_392068726"
      decimals="0"
      id="ixv-6444"
      unitRef="uref_1883446565">10067451</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1230726302"
      decimals="2"
      id="ixv-6445"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_392068726"
      decimals="2"
      id="ixv-6446"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6447"
      unitRef="uref_1538570443">2292576</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_392068726"
      decimals="0"
      id="ixv-6448"
      unitRef="uref_1538570443">1250456</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1230726302"
      decimals="0"
      id="ixv-6449"
      unitRef="uref_1883446565">19110497</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_392068726"
      decimals="0"
      id="ixv-6450"
      unitRef="uref_1883446565">10424325</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1230726302"
      decimals="2"
      id="ixv-6451"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_392068726"
      decimals="2"
      id="ixv-6452"
      unitRef="uref_117607600">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_886717979" id="ixv-3846">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, &#x201c;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d; (&#x201c;ASU 2024-03&#x201d;), and in January 2025 issued ASU 2025-01 &#x201c;Income Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date&#x201d; (&#x201c;ASU-2025-01&#x201d;). ASU 2024-03 and ASU 2025-01 require public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026, and for interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03 and ASU 2025-01.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-04, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments&#x201d;. The amendments in this ASU clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or debt extinguishments. The amendments introduce a preexisting contract approach for evaluating whether induced conversion accounting is appropriate and provide additional guidance regarding the form and amount of consideration transferred in an inducement offer. The standard is effective for fiscal years beginning after December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on its financial statements and related disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-11, &#x201c;Interim Reporting (Topic 270): Narrow-Scope Improvements&#x201d; (&#x201c;ASU 2025-11&#x201d;), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In April 2026, the FASB issued Accounting Standards Update 2026-01, &#x201c;Initial Measurement of Paid-in-Kind Dividends on Equity-Classified preferred Stock&#x201d;, which provides authoritative guidance on how an issuer should initially measure paid-in-kind (&#x201c;PIK&#x201d;) dividends on equity-classified preferred stock. ASU 2026-01 is effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal year reporting periods. Early adoption is permitted in an interim or fiscal year reporting period in which financial statements have not yet been issued or made available for issuance. The Company does not believe ASU 2026-01 will have a significant impact on the Company&#x2019;s financial position, results of operations or cash flows. However, the Company would need to evaluate its impact in the event the Company issues preference shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statement.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dmaa:InitialPublicOfferingTextBlock contextRef="cref_886717979" id="ixv-3861">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 3&#160;&#x2014;&#160;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Pursuant to the Initial Public Offering consummated on January 29, 2025, the Company sold 20,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one right (&#x201c;Public Right&#x201d;), with each Public Right entitling the holder to receive one-eighth (1/8) of one ordinary share upon the consummation of an initial business combination. In connection with the Initial Public Offering, the underwriters were granted a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, if any. On February 18, 2025, the underwriters exercised their option to purchase an additional 3,000,000 Units at a purchase price of $10.00 per Unit, generating additional gross proceeds of $30,000,000. &lt;/p&gt;</dmaa:InitialPublicOfferingTextBlock>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1919088554"
      decimals="0"
      id="ixv-6453"
      unitRef="uref_1883446565">20000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_2139769331"
      decimals="2"
      id="ixv-6454"
      unitRef="uref_117607600">10</us-gaap:SharesIssuedPricePerShare>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_251817079"
      decimals="0"
      id="ixv-6455"
      unitRef="uref_1883446565">1</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1811338515"
      decimals="0"
      id="fc_1811338515"
      unitRef="uref_1883446565">1</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_317406060"
      decimals="0"
      id="ixv-6457"
      unitRef="uref_1883446565">1</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnderwritersOptionPeriodFromDateOfInitialPublicOffering contextRef="cref_1919088554" id="ixv-6458">P45D</dmaa:UnderwritersOptionPeriodFromDateOfInitialPublicOffering>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1730177644"
      decimals="0"
      id="ixv-6459"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_511249785"
      decimals="0"
      id="ixv-6460"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnitPurchasePrice
      contextRef="cref_1828322795"
      decimals="2"
      id="ixv-6461"
      unitRef="uref_117607600">10</dmaa:UnitPurchasePrice>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_511249785"
      decimals="0"
      id="ixv-6462"
      unitRef="uref_1538570443">30000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <dmaa:PrivatePlacementsTextBlock contextRef="cref_886717979" id="ixv-3867">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 4&#160;&#x2014;&#160;PRIVATE PLACEMENT&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 400,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, for $4,000,000, of which $1,100,000 was not received and included as share subscription receivable. Since the Initial Public Offering until June 30, 2026, the Sponsor has paid $649,078 in expenses on behalf of the Company (including $108,300 related to the administrative support agreement) affecting the share subscription receivable on the balance sheet to $450,922. In connection with the Standstill Acknowledgement, the Sponsor acknowledged it is unable to fulfill the financial and operational obligations typically associated with the sponsor role, including providing working capital. As such, the Sponsor will not provide additional funding, and the share subscription receivable has been reduced to $0 as of June 30, 2026 (see Note 8). Each Private Placement Unit consists of one ordinary share and one right to receive one-eighth (1/8) of one ordinary share upon the consummation of an initial business combination. The proceeds from the sale of the Private Placement Units&#160;are added to the net proceeds from the Initial Public Offering held in the Trust Account. Simultaneously with the sale of the over-allotment option Units on February 18, 2025, the Sponsor purchased an additional 30,000 Private Placement Units at a purchase price of $10.00 per Private Placement Unit, generating additional gross proceeds of $300,000. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units&#160;held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). &lt;/p&gt;</dmaa:PrivatePlacementsTextBlock>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssue
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6463"
      unitRef="uref_1883446565">400000</dmaa:UnitsIssuedDuringPeriodSharesNewIssue>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1501621130"
      decimals="2"
      id="ixv-6464"
      unitRef="uref_117607600">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6465"
      unitRef="uref_1538570443">4000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <dmaa:AccruedSubscriptionReceivableNotYetReceivable
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6466"
      unitRef="uref_1538570443">1100000</dmaa:AccruedSubscriptionReceivableNotYetReceivable>
    <dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable
      contextRef="cref_1743778701"
      decimals="0"
      id="ixv-6467"
      unitRef="uref_1538570443">649078</dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable>
    <dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable
      contextRef="cref_1340404045"
      decimals="0"
      id="ixv-6468"
      unitRef="uref_1538570443">108300</dmaa:ExpensesPaidBySponsorUnderShareSubscriptionReceivable>
    <dmaa:ShareSubscriptionReceivable
      contextRef="cref_1105729135"
      decimals="0"
      id="ixv-6469"
      unitRef="uref_1538570443">450922</dmaa:ShareSubscriptionReceivable>
    <dmaa:ShareSubscriptionReceivableReduced
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6470"
      unitRef="uref_1538570443">0</dmaa:ShareSubscriptionReceivableReduced>
    <us-gaap:SaleOfStockDescriptionOfTransaction contextRef="cref_886717979" id="ixv-6471">Each Private Placement Unit consists of one ordinary share and one right to receive one-eighth (1/8) of one ordinary share upon the consummation of an initial business combination.</us-gaap:SaleOfStockDescriptionOfTransaction>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssue
      contextRef="cref_182010128"
      decimals="0"
      id="ixv-6472"
      unitRef="uref_1883446565">30000</dmaa:UnitsIssuedDuringPeriodSharesNewIssue>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_947781037"
      decimals="2"
      id="ixv-6473"
      unitRef="uref_117607600">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_182010128"
      decimals="0"
      id="ixv-6474"
      unitRef="uref_1538570443">300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_886717979" id="ixv-3873">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 5&#160;&#x2014;&#160;RELATED PARTIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On June&#160;17, 2024, the Company issued to the Sponsor an aggregate of 22,361,111 ordinary shares, par value $0.0001 per share, in exchange for $35,000 or approximately $0.0016 per share. On November 6, 2024, the Sponsor surrendered and forfeited 12,503,968 ordinary shares to the Company for no consideration, following which the Sponsor held 9,857,143 ordinary shares (the &#x201c;Founder Shares&#x201d;). All share and per share data has been retrospectively presented. The Founder Shares included an aggregate of up to 1,285,714 shares subject to surrender and forfeiture to the extent that the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the number of Founder Shares will equal, on an as-converted basis, approximately 30% of the Company&#x2019;s issued and outstanding ordinary shares after the Initial Public Offering (not including the Private Placement Units and the representative shares and assuming the Sponsor does not purchase any Public Shares in the Initial Public Offering). On January 29, 2025 the Company completed its Initial Public Offering and the over-allotment option remained unexercised. Subsequently, on February 18, 2025, the underwriters exercised their over-allotment option to purchase an additional 3,000,000 Units. As such, 1,285,714 shares are no longer subject to forfeiture. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor has entered into a letter agreement with the Company pursuant to which, with certain limited exceptions, the Founder Shares and the Private Placement Units, including the underlying securities, are not transferable, assignable or salable (except to directors and officers and other persons or entities affiliated with the Company&#x2019;s initial shareholders, each of whom will be subject to the same transfer restrictions) until the earlier of: (i) with respect to 50% of the Founder Shares and the Private Placement Units, the earlier of six months after the date of the consummation of the initial Business Combination and the date on which the closing price of the Company&#x2019;s ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination and (ii) with respect to the remaining 50% of the Founder Shares and the Private Placement Units, six months after the date of the consummation of the initial Business Combination, or earlier, in either case, if, subsequent to the initial Business Combination, the Company consummates a liquidation, merger, share exchange or other similar transaction which results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Administrative Support Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company has entered into an administrative services agreement, effective on January 7, 2025, pursuant to which the Company has agreed to pay the Sponsor or an affiliate $10,000 for office space, and administrative and support services. The Administrative Services Agreement was cancelled in March of 2026, and the current CEO does not have an agreement in place for current office space, and administrative and support services. For the three and six months ended June 30, 2026, the Company incurred $0 and $30,000 in administrative support fees included in general and administrative costs on the statements of operations, respectively. For the three and six months ended June 30, 2025, the Company incurred $30,000 and $51,000 in administrative support fees included in general and administrative costs on the unaudited statements of operations, respectively. The $30,000 outstanding at the time of cancellation of the Administrative Services Agreement was recorded as a capital contribution in lieu of cash payment to the Sponsor, resulting in no amounts outstanding as of June 30, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On June&#160;13, 2024, the Sponsor issued an unsecured promissory note to the Company (the &#x201c;Promissory Note&#x201d;), pursuant to which the Company may borrow up to an aggregate principal amount of $500,000. On November 21, 2024, the Sponsor amended the Promissory Note to increase the amount the Company may borrow to $750,000. On December 5, 2024, the Sponsor further amended the Promissory Note to increase the amount the Company may borrow to $1,850,000. The Promissory Note is non-interest bearing and was repaid in full in connection with the Company&#x2019;s Initial Public Offering. During the period from May 23, 2024 (inception) through December 31, 2024, the Company received funds totaling approximately $1,700,000 from various investors on behalf of the Sponsor. These monies represent advances paid to the Sponsor for purchase of Founder Shares upon successful completion of the Initial Public Offering. The monies were received on behalf of the Sponsor and deposited into the Company&#x2019;s bank account instead of the Sponsor&#x2019;s bank account. During the period from May 23, 2024 (inception) through December 31, 2024, the Company repaid approximately $1,200,000 of the balance due to the Sponsor related to investments it had received on behalf of the Sponsor, resulting in a balance of approximately $500,000 due to the Sponsor, which is accounted for as part of the promissory note amount on the balance sheets. In conjunction with the Initial Public Offering $900,000 was repaid to the Sponsor, $204,000 in deferred offering costs were paid by the Sponsor and $94,574 in expenses were paid by the Sponsor. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1122482443;"&gt;&lt;span style="-sec-ix-hidden:fc_1585642834;"&gt;no&lt;/span&gt;&lt;/span&gt; outstanding under the promissory note from the related party. The Promissory Note is no longer available for drawdown as it was repaid in full and expired in connection with the Company&#x2019;s Initial Public Offering. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Consulting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the appointment of Saleem Elmasri as Chief Financial Officer and principal financial and accounting officer of the Company on November 17, 2025, the Company entered into a master services agreement (the &#x201c;Consulting Agreement&#x201d;) with Titan Advisory Services LLC for the provision of such principal financial and accounting officer services by Mr. Elmasri. The Consulting Agreement included a Statement of Work (the &#x201c;SoW&#x201d;), pursuant to which the Company will pay Titan Advisory Services LLC $3,500 per month, for services rendered by Mr. Elmasri as Chief Financial Officer. The Company will also grant, or the Company&#x2019;s former CEO shall transfer 100,000 ordinary shares of the Company to Mr. Elmasri. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three and six months ended June 30, 2026, the Company incurred $10,500 and $28,000 (including $7,000 in catch-up amounts retroactively applied for November and December 2025) under the Consulting Agreement and paid $17,500 during the six months ended June 30, 2026, resulting in $10,500 outstanding as of June 30, 2026 recorded to accrued expenses on the unaudited balance sheets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 22, 2026, the Company entered into an updated Statement of Work (the &#x201c;Updated SoW&#x201d;) which increased the number of ordinary shares that Mr. Elmasri is entitled to receive from 100,000 to 175,000, which shall be earned upon execution of a definitive agreement and are to be issued at the closing of the Company&#x2019;s initial business combination, within ten days thereafter. Mr. Elmasri&#x2019;s compensation to be paid by the Company remains unchanged. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;CEO Compensation Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 22, 2026, the Company entered into a compensation agreement (the &#x201c;CEO Compensation Agreement&#x201d;) with Aleutian Equity Holdings LLC, an affiliate of Roger E. Bendelac, the Company&#x2019;s Chief Executive Officer. Pursuant to the CEO Compensation Agreement, Mr. Bendelac (i) is entitled to compensation of $4,500 per month, of which $2,500 is payable currently and up to $2,000 may be deferred based on the Company&#x2019;s cash flow and (ii) as designated recipient, is entitled to receive 250,000 ordinary shares of the Company which shall be earned upon execution of a definitive agreement and are to be issued at the closing of the Company&#x2019;s initial business combination, within ten (10) days thereafter. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three and six months ended June 30, 2026, the Company recorded $18,000 under the Consulting Agreement and paid $13,500, resulting in $4,500 outstanding as of June 30, 2026 recorded to accrued expenses on the unaudited balance sheets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Related Party Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of June 30, 2026 and December 31, 2025, &lt;span style="-sec-ix-hidden:fc_1620669820;"&gt;&lt;span style="-sec-ix-hidden:fc_1300766890;"&gt;no&lt;/span&gt;&lt;/span&gt; working capital loans were outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Amended and Restated Private Units Purchase Agreement and Subscription Promissory Note&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company has entered into an amended and restated private units purchase agreement with the Sponsor, pursuant to which the Sponsor agreed to purchase an aggregate of 400,000 Private Placement Units (or 430,000 Private Placement Units if the underwriters&#x2019; over-allotment is exercised in full) at a price of $10.00 per Private Placement Unit ($4,000,000, or an aggregate of $4,300,000 if the underwriters&#x2019; over-allotment is exercised in full) from the Company in the private placement. Under the agreement, the Sponsor agreed to provide the Company up to $1,100,000 in working capital loans under the subscription promissory note, which loans shall be converted into Private Placement Units, at the price of $10.00 per Unit. To the extent the amount of such loans is less than $1,100,000, the Sponsor agreed that it (or, if applicable, it and any transferees of Private Placement Units) shall surrender for cancellation any and all rights to up to an aggregate of 110,000 Private Placement Units at $10.00 per unit. In connection with the Standstill Acknowledgement, the Sponsor acknowledged it is unable to fulfill the financial and operational obligations typically associated with the sponsor role, including providing working capital. As such, the Sponsor will not provide additional funding. As of June 30, 2026, 45,092 ordinary shares represent the remaining unfunded principal amount of the Subscription Promissory Note. These shares are subject to cancellation and surrender provisions as a result of the Sponsor defaulting on the share subscription receivable. The ordinary shares are presented as issued and outstanding until such time the shares are cancelled or surrendered. See Note 8. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_995603075"
      decimals="0"
      id="ixv-6475"
      unitRef="uref_1883446565">22361111</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2113912987"
      decimals="4"
      id="ixv-6476"
      unitRef="uref_117607600">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_995603075"
      decimals="0"
      id="ixv-6477"
      unitRef="uref_1538570443">35000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_2113912987"
      decimals="4"
      id="ixv-6478"
      unitRef="uref_117607600">0.0016</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1175859534"
      decimals="0"
      id="ixv-6479"
      unitRef="uref_1538570443">12503968</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="cref_995603075"
      decimals="0"
      id="ixv-6480"
      unitRef="uref_1538570443">9857143</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_438570110"
      decimals="0"
      id="ixv-6481"
      unitRef="uref_1538570443">1285714</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <dmaa:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOffering
      contextRef="cref_2113912987"
      decimals="2"
      id="ixv-6482"
      unitRef="uref_379285833">0.30</dmaa:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOffering>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_456329547"
      decimals="0"
      id="ixv-6483"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:NumberOfSharesNoLongerSubjectToForfeited
      contextRef="cref_1622086725"
      decimals="0"
      id="ixv-6484"
      unitRef="uref_1883446565">1285714</dmaa:NumberOfSharesNoLongerSubjectToForfeited>
    <dmaa:PercentageOfShareswhichEarlierOfSixMonthOfInitialBusinessCombination
      contextRef="cref_756791820"
      decimals="2"
      id="ixv-6485"
      unitRef="uref_379285833">0.50</dmaa:PercentageOfShareswhichEarlierOfSixMonthOfInitialBusinessCombination>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_831581933"
      decimals="2"
      id="ixv-6486"
      unitRef="uref_117607600">12.5</us-gaap:SaleOfStockPricePerShare>
    <dmaa:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays contextRef="cref_1087821693" id="ixv-6487">P20D</dmaa:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <dmaa:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays contextRef="cref_1087821693" id="ixv-6488">P30D</dmaa:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <dmaa:PercentageOfSharesRemainingSixMonthOfInitialBusinessCombination
      contextRef="cref_831581933"
      decimals="2"
      id="ixv-6489"
      unitRef="uref_379285833">0.50</dmaa:PercentageOfSharesRemainingSixMonthOfInitialBusinessCombination>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1369455042"
      decimals="0"
      id="ixv-6490"
      unitRef="uref_1538570443">10000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_331261794"
      decimals="0"
      id="ixv-6491"
      unitRef="uref_1538570443">0</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1023210724"
      decimals="0"
      id="ixv-6492"
      unitRef="uref_1538570443">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_863509991"
      decimals="0"
      id="ixv-6493"
      unitRef="uref_1538570443">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_2135065127"
      decimals="0"
      id="ixv-6494"
      unitRef="uref_1538570443">51000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1649255541"
      decimals="0"
      id="ixv-6495"
      unitRef="uref_1538570443">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:ShortTermBorrowings
      contextRef="cref_1181014289"
      decimals="0"
      id="ixv-6496"
      unitRef="uref_1538570443">500000</us-gaap:ShortTermBorrowings>
    <dmaa:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="cref_430900391"
      decimals="0"
      id="ixv-6497"
      unitRef="uref_1538570443">750000</dmaa:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <dmaa:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="cref_602107683"
      decimals="0"
      id="ixv-6498"
      unitRef="uref_1538570443">1850000</dmaa:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <dmaa:PromissoryNotesFunds
      contextRef="cref_1094306799"
      decimals="0"
      id="ixv-6499"
      unitRef="uref_1538570443">1700000</dmaa:PromissoryNotesFunds>
    <dmaa:FundBalanceDueToInvestment
      contextRef="cref_1094306799"
      decimals="0"
      id="ixv-6500"
      unitRef="uref_1538570443">1200000</dmaa:FundBalanceDueToInvestment>
    <dmaa:FundBalanceDueToInvestment
      contextRef="cref_809448938"
      decimals="0"
      id="ixv-6501"
      unitRef="uref_1538570443">500000</dmaa:FundBalanceDueToInvestment>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1094306799"
      decimals="0"
      id="ixv-6502"
      unitRef="uref_1538570443">900000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DeferredOfferingCosts
      contextRef="cref_610905939"
      decimals="0"
      id="ixv-6503"
      unitRef="uref_1538570443">204000</us-gaap:DeferredOfferingCosts>
    <dmaa:SponsorExpensesPaid
      contextRef="cref_1094306799"
      decimals="0"
      id="ixv-6504"
      unitRef="uref_1538570443">94574</dmaa:SponsorExpensesPaid>
    <dmaa:ServiceFeesPerMonth
      contextRef="cref_1556057871"
      decimals="0"
      id="ixv-6505"
      unitRef="uref_1538570443">3500</dmaa:ServiceFeesPerMonth>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="cref_1771782839"
      decimals="0"
      id="ixv-6506"
      unitRef="uref_1883446565">100000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <dmaa:ConsultingAgreementIncurredAmount
      contextRef="cref_1480518319"
      decimals="0"
      id="ixv-6507"
      unitRef="uref_1538570443">10500</dmaa:ConsultingAgreementIncurredAmount>
    <dmaa:ConsultingAgreementIncurredAmount
      contextRef="cref_2098007255"
      decimals="0"
      id="ixv-6508"
      unitRef="uref_1538570443">28000</dmaa:ConsultingAgreementIncurredAmount>
    <dmaa:ConsultingAgreementCatchUpAmounts
      contextRef="cref_1964842653"
      decimals="0"
      id="ixv-6509"
      unitRef="uref_1538570443">7000</dmaa:ConsultingAgreementCatchUpAmounts>
    <us-gaap:PaymentsForFees
      contextRef="cref_1964842653"
      decimals="0"
      id="ixv-6510"
      unitRef="uref_1538570443">17500</us-gaap:PaymentsForFees>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="cref_475012269"
      decimals="0"
      id="ixv-6511"
      unitRef="uref_1538570443">10500</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <dmaa:SaleOfStockSharesReceivedPerTransaction
      contextRef="cref_1885399186"
      decimals="0"
      id="ixv-6512"
      unitRef="uref_1883446565">100000</dmaa:SaleOfStockSharesReceivedPerTransaction>
    <dmaa:SaleOfStockSharesReceivedPerTransaction
      contextRef="cref_1268456083"
      decimals="0"
      id="ixv-6513"
      unitRef="uref_1883446565">175000</dmaa:SaleOfStockSharesReceivedPerTransaction>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1715350485"
      decimals="0"
      id="ixv-6514"
      unitRef="uref_1538570443">4500</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="cref_962785319"
      decimals="0"
      id="ixv-6515"
      unitRef="uref_1538570443">2500</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="cref_409484284"
      decimals="0"
      id="ixv-6516"
      unitRef="uref_1538570443">2000</us-gaap:DeferredCompensationLiabilityCurrent>
    <dmaa:SaleOfStockSharesReceivedPerTransaction
      contextRef="cref_1715350485"
      decimals="0"
      id="ixv-6517"
      unitRef="uref_1883446565">250000</dmaa:SaleOfStockSharesReceivedPerTransaction>
    <us-gaap:ProfessionalFees
      contextRef="cref_1728766642"
      decimals="0"
      id="ixv-6518"
      unitRef="uref_1538570443">18000</us-gaap:ProfessionalFees>
    <us-gaap:PaymentsForFees
      contextRef="cref_1728766642"
      decimals="0"
      id="ixv-6519"
      unitRef="uref_1538570443">13500</us-gaap:PaymentsForFees>
    <us-gaap:ManagementFeePayable
      contextRef="cref_475012269"
      decimals="0"
      id="ixv-6520"
      unitRef="uref_1538570443">4500</us-gaap:ManagementFeePayable>
    <dmaa:DebtInstrumentAmountConvertibleToEquityMaximum
      contextRef="cref_833621421"
      decimals="0"
      id="ixv-6521"
      unitRef="uref_1538570443">1500000</dmaa:DebtInstrumentAmountConvertibleToEquityMaximum>
    <dmaa:ConvertibleUnitPrice
      contextRef="cref_833621421"
      decimals="2"
      id="ixv-6522"
      unitRef="uref_117607600">10</dmaa:ConvertibleUnitPrice>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssue
      contextRef="cref_1834951827"
      decimals="0"
      id="ixv-6523"
      unitRef="uref_1883446565">400000</dmaa:UnitsIssuedDuringPeriodSharesNewIssue>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssue
      contextRef="cref_941713624"
      decimals="0"
      id="ixv-6524"
      unitRef="uref_1883446565">430000</dmaa:UnitsIssuedDuringPeriodSharesNewIssue>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1501621130"
      decimals="2"
      id="ixv-6525"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6526"
      unitRef="uref_1538570443">4000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_892249524"
      decimals="0"
      id="ixv-6527"
      unitRef="uref_1538570443">4300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <dmaa:WorkingCapitalLoans
      contextRef="cref_303774590"
      decimals="0"
      id="ixv-6528"
      unitRef="uref_1538570443">1100000</dmaa:WorkingCapitalLoans>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_618941919"
      decimals="2"
      id="ixv-6529"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:LoansPayable
      contextRef="cref_1946577256"
      decimals="0"
      id="ixv-6530"
      unitRef="uref_1538570443">1100000</us-gaap:LoansPayable>
    <dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6531"
      unitRef="uref_1883446565">110000</dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1501621130"
      decimals="2"
      id="ixv-6532"
      unitRef="uref_117607600">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_458884607"
      decimals="0"
      id="ixv-6533"
      unitRef="uref_1883446565">45092</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:DebtDisclosureTextBlock contextRef="cref_886717979" id="ixv-3950">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 6&#160;&#x2014;&#160;PROMISSORY NOTE, SPONSOR TRANSITION AGREEMENT &amp;amp; EXTENSION ADVANCE NOTE&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On March 23, 2026, the Company issued an interim convertible note (the &#x201c;Interim Note&#x201d;) to the Investor in the principal amount of $100,000 (the &#x201c;Interim Loan&#x201d;). The Interim Loan represents an initial loan towards a contemplated $500,000 financing (the &#x201c;Financing&#x201d;) pursuant to the Definitive Interim Investment and Sponsor Transition Agreement dated March 23, 2026 (the &#x201c;Investment Agreement&#x201d;) described below. As of June 30, 2026, there was $350,000 outstanding under the Interim Note. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Interim Note has a maturity date six months from the date of issuance, unless earlier converted or credited toward the definitive financing under the Investment Agreement and does not bear interest. Upon the consummation of initial business combination by the Company (a &#x201c;Business Combination&#x201d;), the outstanding principal amount of the Interim Loan may, at the option of the Investor, be converted into shares of the combined entity at a conversion price equal to a 35% discount to the market price of such shares at the time of conversion. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On March 23, 2026, the Company entered into the Definitive Interim Investment and Sponsor Transition Agreement, (the &#x201c;Investment Agreement&#x201d;) with the Investor relating to a proposed financing transaction pursuant to which the Investor indicated its intent to provide financing to the Company through a convertible note investment, of which the Interim Loan represented the first tranche. Pursuant to the Investment Agreement, the aggregate amount to be loaned is $500,000. The second tranche of $200,000 will be made within 21 days with the remainder of the commitment on an as-needed basis. The Company also agreed to use commercially reasonable efforts to provide the Investor with not less than 40% of the economic benefit equivalent to sponsor-level economics. The Investor has the right but not the obligation to provide additional funding beyond the $500,000 commitment. As of June 30, 2026, the Investor has not received the economic benefit equivalent to sponsor-level economics in any amount. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company and the Investor have entered into extension advance notes (the &#x201c;Extension Advance Notes&#x201d;) pursuant to which the Investor&#x2019;s extension deposits, which is the lessor of $300,000 or $0.04 per non-redeemed public share, are repayable to the Investor at or following the closing of the Company&#x2019;s business combination. In lieu of reimbursement, the Investor may elect, in its sole discretion and by written notice given at or prior to the closing, to convert the principal amount of the Extension Advance Notes into ordinary shares of the post-combination company at a price per share equal to the Reference Price, as defined in Omnibus Amendment No. 3 to the Merger Agreement and as it may be amended. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Extension Advance Notes are issued in respect of extension funding provided under the Investment, under which the Investor has the right, but not the obligation, to provide additional financing including extension funding. Amounts advanced under the Extension Advance Notes are additional to, and shall not be credited against, the Investor&#x2019;s commitment of up to $500,000 under the Investment Agreement, which is separately evidenced by the Interim Convertible Notes. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Investor has made two deposits of $300,000, or $600,000 in the aggregate, during the three and six months ended June 30, 2026, resulting in an Extension Advance Notes balance of $600,000 as of June 30, 2026. &lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1895244941"
      decimals="0"
      id="ixv-6534"
      unitRef="uref_1538570443">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="cref_1637280617"
      decimals="0"
      id="ixv-6535"
      unitRef="uref_1538570443">500000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6536"
      unitRef="uref_1538570443">350000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:DebtInstrumentTerm contextRef="cref_376705632" id="ixv-6537">P6M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="cref_376705632"
      decimals="2"
      id="ixv-6538"
      unitRef="uref_379285833">0.35</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="cref_900816929"
      decimals="0"
      id="ixv-6539"
      unitRef="uref_1538570443">500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:OtherNotesPayable
      contextRef="cref_374279680"
      decimals="0"
      id="ixv-6540"
      unitRef="uref_1538570443">200000</us-gaap:OtherNotesPayable>
    <us-gaap:OtherCommitment
      contextRef="cref_1835452059"
      decimals="0"
      id="ixv-6541"
      unitRef="uref_1538570443">500000</us-gaap:OtherCommitment>
    <us-gaap:Deposits
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6542"
      unitRef="uref_1538570443">300000</us-gaap:Deposits>
    <dmaa:NonRedeemedPublicPerShare
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6543"
      unitRef="uref_117607600">0.04</dmaa:NonRedeemedPublicPerShare>
    <dmaa:InvestorCommitmentAmount
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6544"
      unitRef="uref_1538570443">500000</dmaa:InvestorCommitmentAmount>
    <us-gaap:PaymentsForDeposits
      contextRef="cref_259218133"
      decimals="0"
      id="ixv-6545"
      unitRef="uref_1538570443">300000</us-gaap:PaymentsForDeposits>
    <us-gaap:PaymentsForDeposits
      contextRef="cref_414021520"
      decimals="0"
      id="ixv-6546"
      unitRef="uref_1538570443">600000</us-gaap:PaymentsForDeposits>
    <dmaa:ExtensionAdvanceNotesBalance
      contextRef="cref_32152629"
      decimals="0"
      id="ixv-6547"
      unitRef="uref_1538570443">600000</dmaa:ExtensionAdvanceNotesBalance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_886717979" id="ixv-3973">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 7&#160;&#x2014;&#160;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the rising conflict between Russia and Ukraine, and the rising conflicts in the Middle East, and resulting market volatility could adversely affect the Company&#x2019;s ability to complete a Business Combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In addition to the Russia-Ukraine conflict, the U.S.-Israel-Iran conflict has had immediate and substantial effects on global trade, energy markets and financial markets. Disruptions to critical maritime shipping routes have led major shipping companies and tanker operators to suspend or reroute operations, increasing transit times and freight costs and causing widespread supply chain disruptions. Insurance coverage for certain high-risk areas has become more costly or unavailable, and regional airspace closures have adversely affected commercial aviation. These developments have contributed to volatility in global commodity prices, including oil, and have resulted in declines in global equity markets and increased demand for safe-haven assets. The evolving conflict environment has also led to heightened sanctions enforcement and increased compliance risks in financial markets.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Any of the above factors, including sanctions, export controls, tariffs, trade wars and other geopolitical actions, could have a material adverse effect on the Company&#x2019;s ability to complete a Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The holders of the Founder Shares, Private Placement Units&#160;(and underlying securities) and any Private Placement Units&#160;(and underlying securities) that may be issued on conversion of working capital loans are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggy-back registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. However, the registration rights agreement will provide that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Underwriting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company granted the underwriters a 45-day option from the date of the final prospectus dated January 27, 2025, to purchase up to 3,000,000 additional Units&#160;to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On February 18, 2025, the underwriters exercised their option in full to purchase an additional 3,000,000 Units at a purchase price of $10.00 per Unit, generating additional gross proceeds of $30,000,000. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The underwriters were entitled to a cash underwriting discount of $0.05 per Unit, or 0.5% of the gross proceeds of the Initial Public Offering, or $1,000,000 in the aggregate (or up to $1,150,000 if the over-allotment option is exercised in full), paid at the closing of the Initial Public Offering and the $150,000 was paid on the closing of the over-allotment option. In addition, the underwriters are entitled to a deferred fee of $0.30&#160;per Unit, or 3.0% of the gross proceeds of the Initial Public Offering, or $6,900,000 in the aggregate, of which 25.0% will be adjusted net of redemptions (i.e., for purposes of calculating the deferred underwriting commission net of redemptions, 25.0% of the deferred underwriting commissions will determined by the dollar amount that is product of (i) 3.0% multiplied by the product of the number of unredeemed public shares, multiplied by $10.00 and (ii) 25.0%). In connection with the Redemption, the deferred underwriting fee was reduced, pursuant to the above calculation, by $708,000. As such, as of June 30, 2026 and December 31, 2025, the deferred underwriting fee payable was $6,192,000 and $6,900,000, respectively. The deferred fee becomes payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In addition, the Company agreed to issue the underwriters 230,000 ordinary shares, denoted as representative shares. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <dmaa:TermOfUnderwritersGrantedOptionsFromTheProspectus contextRef="cref_1220412094" id="ixv-6548">P45D</dmaa:TermOfUnderwritersGrantedOptionsFromTheProspectus>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_158101399"
      decimals="0"
      id="ixv-6549"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1627013684"
      decimals="0"
      id="ixv-6550"
      unitRef="uref_1883446565">3000000</dmaa:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1551556043"
      decimals="2"
      id="ixv-6551"
      unitRef="uref_117607600">10</us-gaap:SharesIssuedPricePerShare>
    <dmaa:ProceedsFromOverAllotmentOption
      contextRef="cref_1627013684"
      decimals="0"
      id="ixv-6552"
      unitRef="uref_1538570443">30000000</dmaa:ProceedsFromOverAllotmentOption>
    <dmaa:CashUnderwritingDiscount
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6553"
      unitRef="uref_117607600">0.05</dmaa:CashUnderwritingDiscount>
    <dmaa:UnderwritingDiscountGrossProceedsPercentage
      contextRef="cref_886717979"
      decimals="3"
      id="ixv-6554"
      unitRef="uref_379285833">0.005</dmaa:UnderwritingDiscountGrossProceedsPercentage>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_318403519"
      decimals="0"
      id="ixv-6555"
      unitRef="uref_1538570443">1000000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_892249524"
      decimals="0"
      id="ixv-6556"
      unitRef="uref_1538570443">1150000</us-gaap:PaymentsForUnderwritingExpense>
    <dmaa:PaymentOnOverallotmentOption
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6557"
      unitRef="uref_1538570443">150000</dmaa:PaymentOnOverallotmentOption>
    <dmaa:DeferredUnderwritingCommissionDescription contextRef="cref_886717979" id="ixv-6558">In addition, the underwriters are entitled to a deferred fee of $0.30&#160;per Unit, or 3.0% of the gross proceeds of the Initial Public Offering, or $6,900,000 in the aggregate, of which 25.0% will be adjusted net of redemptions (i.e., for purposes of calculating the deferred underwriting commission net of redemptions, 25.0% of the deferred underwriting commissions will determined by the dollar amount that is product of (i) 3.0% multiplied by the product of the number of unredeemed public shares, multiplied by $10.00 and (ii) 25.0%). In connection with the Redemption, the deferred underwriting fee was reduced, pursuant to the above calculation, by $708,000. As such, as of June 30, 2026 and December 31, 2025, the deferred underwriting fee payable was $6,192,000 and $6,900,000, respectively. The deferred fee becomes payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</dmaa:DeferredUnderwritingCommissionDescription>
    <dmaa:DeferredFeesPerUnit
      contextRef="cref_886717979"
      decimals="2"
      id="ixv-6559"
      unitRef="uref_117607600">0.3</dmaa:DeferredFeesPerUnit>
    <dmaa:GrossProceedPercentage
      contextRef="cref_318403519"
      decimals="3"
      id="ixv-6560"
      unitRef="uref_379285833">0.03</dmaa:GrossProceedPercentage>
    <dmaa:AggregateDeferredFees
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6561"
      unitRef="uref_1538570443">6900000</dmaa:AggregateDeferredFees>
    <dmaa:RedemptionAdjustedPercentage
      contextRef="cref_886717979"
      decimals="3"
      id="ixv-6562"
      unitRef="uref_379285833">0.25</dmaa:RedemptionAdjustedPercentage>
    <dmaa:DeferredUnderwritingFeesPercentage
      contextRef="cref_886717979"
      decimals="3"
      id="ixv-6563"
      unitRef="uref_379285833">0.25</dmaa:DeferredUnderwritingFeesPercentage>
    <dmaa:NumberOfRepresentativeShares
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6564"
      unitRef="uref_1883446565">230000</dmaa:NumberOfRepresentativeShares>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_886717979" id="ixv-4008">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 8&#160;&#x2014;&#160;SHAREHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&#160;&lt;/i&gt;&lt;/span&gt;&#x2014;&#160;The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_730429292;"&gt;&lt;span style="-sec-ix-hidden:fc_26525541;"&gt;&lt;span style="-sec-ix-hidden:fc_531165682;"&gt;&lt;span style="-sec-ix-hidden:fc_1421247184;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Ordinary Shares&#160;&lt;/i&gt;&lt;/span&gt;&#x2014;&#160;The Company is authorized to issue 220,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. On March 11, 2025, the Company issued 200,000 ordinary shares to an investor of the Sponsor for no consideration. These shares were to be transferred from the ordinary shares held by the Sponsor. However, new ordinary shares were issued instead. As of June 30, 2026 and December 31, 2025, there are 10,717,143 ordinary shares issued and outstanding, excluding 13,559,770 and 23,000,000 shares subject to redemption, respectively. Of the ordinary shares outstanding at June 30, 2026 and December 31, 2025 an aggregate of up to 45,092 ordinary shares were subject to cancellation and surrender provisions as a result of the Sponsor defaulting on the share subscription receivable. The ordinary shares are presented as issued and outstanding until such time the shares are cancelled or surrendered. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Rights&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive one-eighth (1/8) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-eighth (1/8) of one ordinary share underlying each right upon consummation of the Business Combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Representative Shares&lt;/i&gt;&lt;/span&gt; &#x2014; The Company issued to Clear Street LLC, the representative of the underwriters in the Initial Public Offering, 200,000 ordinary shares (the &#x201c;representative shares&#x201d;) at the time of the consummation of Initial Public Offering and 30,000 representative shares at the closing of the over-allotment option. The holders of the representative shares have agreed (i) that they will not transfer, assign or sell any such shares without our prior consent until the completion of the initial Business Combination, (ii) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within 15 months from the closing of the Initial Public Offering (or up to 21 months from the closing if the Company extends the period of time to consummate a Business Combination). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The representative shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales of the Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA&#x2019;s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales of the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the commencement of sales of the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Subscription Receivable&lt;/i&gt;&lt;/span&gt; &#x2014; On January 29, 2025, the Company issued a new unsecured subscription promissory note to the Sponsor in connection with the amended and restated units purchase agreement (as described in Note 5) pursuant to which the Company may borrow up to an aggregate principal amount of $1,100,000 working capital loans. The Sponsor further agrees that such loans shall be converted into Private Units, at the price of $10.00 per unit. To the extent the amount of such loans is less than $1,100,000, the Sponsor acknowledges and agrees that it (or, if applicable, it and any transferees of Private Units) shall surrender for cancellation any and all rights to up to an aggregate of 110,000 Private Units at $10.00 per unit. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the Standstill Acknowledgement, the Sponsor acknowledged it is unable to fulfill the financial and operational obligations typically associated with the sponsor role, including providing working capital. As such, the Sponsor will not provide additional funding. As of June 30, 2026, 45,092 ordinary shares represent the remaining unfunded principal amount of the Subscription Promissory Note. These shares are subject to cancellation and surrender provisions as a result of the Sponsor defaulting on the share subscription receivable. The ordinary shares are presented as issued and outstanding until such time the shares are cancelled or surrendered. As such, as of June 30, 2026 and December 31, 2025, the share subscription receivable was $0. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6565"
      unitRef="uref_1883446565">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_981018279"
      decimals="4"
      id="ixv-6566"
      unitRef="uref_117607600">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6567"
      unitRef="uref_1883446565">220000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_981018279"
      decimals="4"
      id="ixv-6568"
      unitRef="uref_117607600">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="cref_291828659" id="ixv-6569">one</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1653239288"
      decimals="0"
      id="fc_1653239288"
      unitRef="uref_1883446565">200000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6571"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6572"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6573"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6574"
      unitRef="uref_1883446565">10717143</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6575"
      unitRef="uref_1883446565">13559770</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6576"
      unitRef="uref_1883446565">23000000</us-gaap:TemporaryEquitySharesOutstanding>
    <dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_291828659"
      decimals="0"
      id="ixv-6577"
      unitRef="uref_1883446565">45092</dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues>
    <dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1959642219"
      decimals="0"
      id="ixv-6578"
      unitRef="uref_1883446565">45092</dmaa:SurrenderedAndCancellationOfUnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_10952121"
      decimals="0"
      id="ixv-6579"
      unitRef="uref_1883446565">200000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_27942075"
      decimals="0"
      id="ixv-6580"
      unitRef="uref_1883446565">30000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <dmaa:PeriodFromTheClosingOfTheInitialPublicOffering contextRef="cref_36948847" id="ixv-6581">P15M</dmaa:PeriodFromTheClosingOfTheInitialPublicOffering>
    <dmaa:PeriodFromTheClosingOfTheInitialPublicOffering contextRef="cref_868159221" id="ixv-6582">P21M</dmaa:PeriodFromTheClosingOfTheInitialPublicOffering>
    <dmaa:DeemedCompensationForLockUpPeriod contextRef="cref_886717979" id="ixv-6583">P180D</dmaa:DeemedCompensationForLockUpPeriod>
    <dmaa:WorkingCapitalLoans
      contextRef="cref_1979039315"
      decimals="0"
      id="ixv-6584"
      unitRef="uref_1538570443">1100000</dmaa:WorkingCapitalLoans>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_1883792367"
      decimals="2"
      id="ixv-6585"
      unitRef="uref_117607600">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_1979039315"
      decimals="0"
      id="ixv-6586"
      unitRef="uref_1538570443">1100000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="cref_519137305"
      decimals="0"
      id="ixv-6587"
      unitRef="uref_1883446565">110000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <dmaa:PrivateUnitPricePerShare
      contextRef="cref_117607600"
      decimals="2"
      id="ixv-6588"
      unitRef="uref_117607600">10</dmaa:PrivateUnitPricePerShare>
    <dmaa:UnfundedPrincipalAmountOfOrdinaryShares
      contextRef="cref_886717979"
      decimals="0"
      id="ixv-6589"
      unitRef="uref_1883446565">45092</dmaa:UnfundedPrincipalAmountOfOrdinaryShares>
    <dmaa:ShareSubscriptionReceivableAmount
      contextRef="cref_981018279"
      decimals="0"
      id="ixv-6590"
      unitRef="uref_1538570443">0</dmaa:ShareSubscriptionReceivableAmount>
    <dmaa:ShareSubscriptionReceivableAmount
      contextRef="cref_67661748"
      decimals="0"
      id="ixv-6591"
      unitRef="uref_1538570443">0</dmaa:ShareSubscriptionReceivableAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_886717979" id="ixv-4046">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 9&#160;&#x2014;&#160;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 24px;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 72px;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;1:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;2:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Observable inputs other than Level&#160;1 inputs. Examples of Level&#160;2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0;"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 24px;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 72px;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;3:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin: 0;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following tables present information about the Company&#x2019;s financial instruments that are measured at fair value as of June 30, 2026 and December 31, 2025 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;June 30, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;146,834,251&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="font-style: italic;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;1&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;239,906,656&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="cref_886717979" id="ixv-4088">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following tables present information about the Company&#x2019;s financial instruments that are measured at fair value as of June 30, 2026 and December 31, 2025 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;June 30, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;146,834,251&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="font-style: italic;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center;"&gt;1&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;239,906,656&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_1314155591"
      decimals="0"
      id="ixv-6592"
      unitRef="uref_1538570443">146834251</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_758851163"
      decimals="0"
      id="ixv-6593"
      unitRef="uref_1538570443">239906656</us-gaap:AssetsHeldInTrust>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_886717979" id="ixv-4147">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE&#160;10 &#x2014;&#160;SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;ASC Topic&#160;280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers.&#160;Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), or group, in deciding how to allocate resources and assess performance.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_1833366445;"&gt;Chief Executive Officer&lt;/span&gt;, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has &lt;span style="-sec-ix-hidden:fc_1025653295;"&gt;one&lt;/span&gt; operating segment. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheets as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews key metrics, which includes general and administrative expenses and interest earned on cash and investments held in Trust Account which are included in the accompanying statements of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key metrics included in segment profit or loss reviewed by the CODM are interest earned on cash and investments held in Trust Account and general and administrative costs. The CODM reviews interest earned on cash and investments held in the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the Combination Period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_886717979" id="ixv-4154">The Company&#x2019;s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_886717979" id="ixv-4162">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 11&#160;&#x2014;&#160;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheets and through the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, other than those disclosed below.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On July 14, 2026, the Boards of Directors of the Company and PAGC approved a third amendment to the Merger Agreement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 27, 2026, the Investor deposited $300,000 into the Trust Account to extend the Company by one (1) month. Accordingly, the deposit was recorded against the Extension Advance Notes, resulting in a balance of $900,000. &lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <dmaa:InvestorDepositedIntoTheTrustAccount
      contextRef="cref_1538570443"
      decimals="0"
      id="ixv-6594"
      unitRef="uref_1538570443">300000</dmaa:InvestorDepositedIntoTheTrustAccount>
    <dmaa:ExtensionAdvanceNotesBalance
      contextRef="cref_1538570443"
      decimals="0"
      id="ixv-6595"
      unitRef="uref_1538570443">900000</dmaa:ExtensionAdvanceNotesBalance>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_836361269" id="ixv-6596">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_836361269" id="ixv-6597">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_836361269" id="ixv-6598">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_836361269" id="ixv-6599">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_378623981"
          xlink:label="fc_378623981"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1260456169"
          xlink:label="fc_1260456169"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1336707000"
          xlink:label="fc_1336707000"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1386784382"
          xlink:label="fc_1386784382"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_60159976"
          xlink:label="fc_60159976"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_132155173"
          xlink:label="fc_132155173"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_26115652"
          xlink:label="fc_26115652"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_254486411"
          xlink:label="fc_254486411"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_328050879"
          xlink:label="fc_328050879"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1040376686"
          xlink:label="fc_1040376686"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2114507352"
          xlink:label="fc_2114507352"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_372359134"
          xlink:label="fc_372359134"
          xlink:type="locator"/>
        <link:footnote id="fref_1122068495" xlink:label="fref_1122068495" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 45,092 ordinary shares subject to cancellation and surrender as a result of Sponsor default on the share subscription receivable. The ordinary shares are issued and outstanding as of June 30, 2026 December 31, 2025 and are pending cancellation and surrender. See Note 8.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_378623981"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1260456169"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1336707000"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1386784382"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_60159976"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_132155173"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_26115652"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_254486411"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_328050879"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1040376686"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2114507352"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_372359134"
          xlink:to="fref_1122068495"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_2022202765"
          xlink:label="fc_2022202765"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_560203315"
          xlink:label="fc_560203315"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1690641320"
          xlink:label="fc_1690641320"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1961347033"
          xlink:label="fc_1961347033"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1274856978"
          xlink:label="fc_1274856978"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_113759514"
          xlink:label="fc_113759514"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1238118164"
          xlink:label="fc_1238118164"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1751589701"
          xlink:label="fc_1751589701"
          xlink:type="locator"/>
        <link:footnote id="fref_953447088" xlink:label="fref_953447088" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 45,092 ordinary shares subject to cancellation and surrender provisions as a result of the Sponsor defaulting on the share subscription receivable. The ordinary shares are presented as issued and outstanding until such time they are cancelled and surrendered. See Note 8.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2022202765"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_560203315"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1690641320"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1961347033"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1274856978"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_113759514"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1238118164"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1751589701"
          xlink:to="fref_953447088"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_905155818"
          xlink:label="fc_905155818"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1201987494"
          xlink:label="fc_1201987494"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_969392038"
          xlink:label="fc_969392038"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_791060277"
          xlink:label="fc_791060277"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1510992032"
          xlink:label="fc_1510992032"
          xlink:type="locator"/>
        <link:footnote id="fref_500177644" xlink:label="fref_500177644" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As a result of the redemption of Class A ordinary shares, the deferred underwriting fee payable was reduced in accordance with the Underwriting Agreement. See Note 7.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_905155818"
          xlink:to="fref_500177644"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1201987494"
          xlink:to="fref_500177644"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_969392038"
          xlink:to="fref_500177644"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_791060277"
          xlink:to="fref_500177644"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1510992032"
          xlink:to="fref_500177644"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
